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Summary
The work in the three presented articles provides several demonstrations of 
how an integrative approach to scientific research has led to a better understand 
of  biological  phenomena.  The  first  article  incorporates  research  from  the 
overlapping fields of biotechnology, functional genomics, and bioinformatics. The 
study's objective is to describe the nature of the distribution of gene expression 
levels  measured  with  microarrays  with  the  aim  of  developing  an  inter-array 
normalization method. The normalization method is compared to other existing 
normalization methods and is found to be especially suited to so-called boutique 
microarrays. The second article uses genotyping data generated by microarrays 
with  the  goal  of  examining  the  population  genetic  structure  of  the  European 
human population.  This study combines aspects of  the fields of  biotechnology, 
bioinformatics, and population genetics and sheds light on the genetic differences 
between Europeans by characterizing a strong correlation between geographic 
and genetic distance. In the final article, focus switches from genetic differences to 
genetic similarities in the same European individuals by examining the relationship 
structure of  genetic  nearest  neighbors.  Observations about  these relationships 
lead to the proposal  of a genetic matched-pair  study design that contributes a 
methodological improvement to the field of genetic epidemiology. The proposed 
study design has the potential to increase the power of analysis of genome-wide 
association  studies  which  are  used  to  discover  disease-causing  genes.  A 
presentation of previously unpublished research which was generated during the 
course  of  the  work  is  also  included.  Finally,  a  discussion  of  long-tail  data 
distributions  initially  observed  in  the  first  article  leads  to  conclusions  on  the 
fundamental  properties  of  the  informational  content  of  genetic  marker  sets 
ascertained in the last two articles.
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Zusammenfassung
Die  Arbeiten,  die  in  den  drei  vorliegenden  Artikeln  präsentiert  werden, 
zeigen,  wie  ein  integrativer  wissenschaftlicher  Ansatz  zu  einem  besseren 
Verständnis biologischer Phänomene führt. Der erste Artikel verknüpft Forschung 
aus den sich überlappenden Fachgebieten Biotechnologie, funktionelle Genomik 
und  Bioinformatik.  Das  Ziel  der  Studie  war  es,  mittels  Mikroarrays  die 
Verteilungsform  der  Genexpressionsniveaus  zu  bestimmen,  um  eine 
Normalisierungsmethode  zu  entwickeln.  Diese  Normalisierungsmethode  wurde 
mit  anderen  bereits  bekannten  Normalisierungsmethoden  verglichen  und  sie 
erwies  sich  als  besonders  geeignet  für  sogenannte  Boutique-Mikroarrays.  Der 
zweite Artikel verfolgt das Ziel, mit Hilfe von humanen Genotypisierungsdaten aus 
Mikroarrays die populationsgenetische Struktur der europäischen Population zu 
charakterisieren.  Diese  Studie  verbindet  Aspekte  der  Forschungsgebiete 
Biotechnologie, Bioinformatik und Populationsgenetik und gibt damit Aufschluss 
über die Muster genetischer Unterschiede zwischen Europäern: Es konnte eine 
hohe Korrelation zwischen geographischen und genetischen Distanzen gezeigt 
werden. Der letzte Artikel richtet den Blick auf die genetischen Gemeinsamkeiten 
der selben europäischen Individuen, indem er die Verwandtschaftsstruktur mittels 
eines genetischen „nearest neighbors“-Algorithmus untersucht. Die beobachteten 
Verwandtschaftsstrukturen  führen  zum  Vorschlag  eines  genetischen  Matched-
Pair-Studiendesigns,  das  auf  dem Gebiet  der  genetischen  Epidemiologie  eine 
erhebliche  methodische  Verbesserung  darstellt.  Das  vorgeschlagene 
Studiendesign  kann  die  Aussagekraft  der  statistischen  Analysen  bei  Genom-
weiten Assoziationsstudien erhöhen, also bei Studien, die durchgeführt werden, 
um  krankheitsverursachende  Gene  zu  identifizieren.  Darüber  hinaus  werden 
bisher unveröffentlichte Forschungsergebnisse vorgestellt, die im Zusammenhang 
mit den obigen Studien gewonnen wurden.  Eine abschließende Diskussion der 
Long-Tailed-Verteilung der Daten, die zunächst in der ersten Studie beobachtet 
wurde, führt zu Schlussfolgerungen über die grundlegenden Eigenschaften des 
Informationsgehaltes genetischer Markersets, welche nachfolgend in den letzten 
beiden Studien bestätigt wurden.
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Introduction
Overview
The work presented in this thesis spans five broad fields of biological study, 
which  are  biotechnology,  population  genetics,  genetic  epidemiology,  functional 
genomics,  and  bioinformatics  (Table  1).  These  diverse  fields  and  the  overlap 
between them provide the foundation upon which the research presented in this 
thesis is based. Because this thesis draws from narrower areas of research from 
within each of these broad fields, a general overview of each field will be followed 
by more specific background information required to place the research presented 
in the three articles that follow in the necessary context. In the first article, a novel 
normalization  method  for  expression  microarrays  is  proposed  and  evaluated. 
Concepts introduced in this article draw from the fields of functional genomics, 
biotechnology,  and  bioinformatics.  Article  two  examines  the  genetic  structure 
present in the European human population, making use of genotypes generated 
using microarray technology to examine a population genetic question. The thesis 
culminates  in  the  evaluation  of  a  novel  method  for  controlling  for  population 
stratification in genome wide association studies, drawing from the diverse fields 
population genetics, genetic epidemiology, and biotechnology. Because each of 
the general topics are very broad, only the background information relevant to 
each of the categories will be discussed; however, the interested reader will find 
more detailed material provided in the introduction to each of the articles.
Table putting the articles 
presented in this thesis into 
the context of broader fields 
of biological research. All 
thesis articles have been 
previously published under 
primary authorship. Other 
publications as supporting 
author are listed along with 
publication reference numbers 
in the Curriculum vitae.
Table 1. Integrated Areas of Research
Thesis Article
Area of Research 1 2 3
Biotechnology • • •
Population Genetics • •
Genetic Epidemiology •
•
• •
Publication reference number (see CV) 14 2 1
Functional Genomics
Bioinformatics
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The  articles  presented  in  this  thesis  have  been  previously  published 
elsewhere. The references to the three publications corresponding to the articles 
are as follows:
1.  Lu,  et.  al.  Can  Zipf's  law  be  adapted  to  normalize  microarrays?  BMC 
Bioinformatics. 2005 ;6:37.
2.  Lao & Lu*, et. al. Correlation between genetic and geographic structure in 
Europe. Curr Biol. 2008 Aug 26;18(16):1241-8.
3.  Lu & Lao*, et. al.. An evaluation of the genetic-matched pair study design 
using  genome-wide  SNP data  from the  European population.  Eur  J  Hum 
Genet. 2009 Jan 21;[online advanced publication] doi:10.1038/ejhg.2008.266
* shared first authorship.
Biotechnology - Microarray Technology
Biotechnology differs from the other fields of study previously mentioned in 
the  sense  that  it  is  not  a  classical  academic  subject  of  study  but  instead  a 
collection of tools,  techniques and methods used to facilitate the acquisition of 
knowledge from various other fields of biological research. Even so, fundamental 
research in biotechnology is an important  endeavor wherein scientists develop 
novel  methods  of  observing  physical  phenomena  as  well  as  increase  the 
efficiency and sensitivity of existing analytical techniques. The overlap between 
biotechnology  and  other  fields  of  study,  such  as  bioinformatics,  functional 
genomics,  genetic  epidemiology,  and  population  genetics  is  an  area  where 
knowledge  can  be  combined  to  spur  scientific  discovery.  Innovations  in  these 
areas  often  allow  research  to  proceed  in  directions  not  previously  anticipated 
under the previous scientific  framework. An example of one such revolutionary 
advance in biotechnology is DNA microarray technology, which makes a recurring 
appearance throughout this thesis and is one of the foundation technologies upon 
which this work is based. 
Microarray technology has been at the leading edge of advancements in 
both the speed and scale of data collection in many areas of molecular and cell 
biology since its development in the mid-1990's as a high-throughput method for 
measuring gene expression1, it came into widespread use in the late-1990's2 and 
was soon adapted to be used for analyzing genotypes3, sequencing DNA4 and 
detecting mRNA splice variants5. It continues to be a field of rapid technological 
development. As microarray research advanced, the technology moved out of the 
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academic  research environment  to  be developed as application oriented high-
throughput commercial systems. The continued success of microarray technology 
is attributable to three main factors. First, experiments can be performed with very 
small quantities of test material, typically in the range of nanograms to picograms, 
presenting  a  significant  improvement  over  previous  technologies.  Second, 
microarrays further increase experimental efficiency by miniaturizing the physical 
format upon which an individual experiment takes place. The number of targets 
which can be screened simultaneously ranges from the thousands to the millions 
depending on the type of array. Third, microarrays are flexible. Expanding on the 
basic idea of the expression microarray by varying the type of targets, probes, or 
chemistry  of  the  system  is  a  powerful  way  of  developing  microarrays  with 
completely novel purposes. 
The description of microarrays presented here focuses on the expression 
type of array as this was the first to be developed. At the most fundamental level, 
a microarray experiment begins with single stranded DNA of a known sequence 
(target) covalently bound to a solid support material. A mixture of unknown single 
stranded DNAs (probe) is applied to the support with the purpose of detecting a 
match, which occurs when the target and one of the probes hybridize. Detection is 
facilitated by a label (i.e. radioactive, fluorescent or chemiluminescent) that tags 
the target-probe DNA hybrid. A scanner is used to quantify the amount of label 
present at the target-probe hybrid. Many different target DNAs are arranged in a 
grid pattern on the solid support  which is then referred to as an “array”.  Early 
microarrays were manufactured by physically spotting target  solutions onto the 
solid  support,  thus target  DNA locations are sometimes referred to as “spots”. 
With all microarray systems, the location of the spot and thereby the mapping of 
the target sequence to a physical position is critical to the final interpretation of 
target activity. One distinctive feature of microarrays that makes them especially 
powerful is the large number of spots (thousands to a million) spaced very closely 
together  on the solid  support.  The spots  are  typically  on the  scale  of  tens  of 
micrometers in diameter and the whole array a few millimeters in size, thus the 
descriptive name “microarray”. By decreasing the size of spots and/or increasing 
their  physical proximity it  is possible to increase the number of  measurements 
collected  in  a  single  experiment  sometimes  gaining  exponential  increases  in 
efficiency. In fact, it has even been proposed that the process of miniaturization 
and corresponding increase in throughput for microarrays may have parallels with 
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Moore's  Law,  which  describes  price  decreases  corresponding  to  performance 
increases in computer chips6. Microarrays have found application in many fields of 
genetics, molecular biology, and cell biology. The use of microarrays in this thesis 
is limited to the specialized fields of population genetics, genetic epidemiology and 
functional genomics where two distinct types of microarray systems were used, 
one for quantifying the level of gene expression, and one for genotyping genetic 
markers. 
Gene  expression  measurement  was  the  original  purpose  for  which 
microarrays were developed. The term “gene expression” is used to describe the 
quantified  level  of  activity  of  a  gene.  An estimated  thirty  thousand  genes  are 
present in the human genome7, each with its own pattern of regulation and a level 
of expression that varies with the cells' environment. To understand the concept of 
quantifying gene expression, it is useful to recall the textbook central dogma of 
molecular  biology8 coined by  Frances Crick  in  1958 which  states that  DNA is 
transcribed  to  RNA  which  is,  in  turn,  translated  to  protein.  In  microarrays, 
measurement of gene expression is accomplished by extracting messenger RNA 
(mRNA) from a sample, converting it to complimentary DNA (cDNA) which is then 
labeled and used to probe the microarray, which is itself spotted cDNA of known 
sequence from a library of expressed genes. Genes expressed at a high level will 
have correspondingly high levels of messenger RNA present in the sample extract 
and therefore high levels of  cDNA probe that  hybridize to the target.  Similarly, 
genes with low expression levels, or genes that are not expressed at all, will have 
correspondingly low target binding activity. 
Genotyping is the other purpose to which microarrays are tasked in the 
work presented here. Genotyping is done using microarrays designed to detect 
single base-pair changes in the DNA sequence. The genetic variants occurring at 
this  most  fundamental  level  of  the  genome  are  called  single  nucleotide 
polymorphisms (SNPs). The human genome contains approximately fifteen million 
SNPs according  to  one  estimate9,  making  them ideal  genetic  markers  for  the 
study of human genetics diseases, for example. Microarrays designed to detect 
SNPs differ from those used to quantify gene expression in many respects making 
them a good example for demonstrating the flexibility of microarray technology by 
showing how the same basic concept can be used in a different context by varying 
the selection of probes, targets, and hybridization chemistry10. For example, the 
probes used on  expression  microarrays  are  cDNA synthesized  from extracted 
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mRNA. In contrast,  for genotyping microarrays,  probes are derived from whole 
genomic DNA. In a similar vein, the targets on expression microarrays are gene 
transcripts, usually from cDNA libraries, representing only coding regions of the 
genome, whereas the targets on genotyping microarrays are the allele specific 
oligonucleotides, which may occur almost anywhere in the genome. Furthermore, 
in  expression microarrays,  the detection chemistry  is optimized to quantify  the 
amount  of  probe  hybridized  to  the  target.  In  contrast,  typical  genotyping 
microarrays have a more complex chemistry that allows differentiation between 
two alternate genetic variants (alleles) using two florescent markers of different 
color.  The expression microarrays presented in Article One of  this thesis were 
designed to evaluate approximately thirty thousand target genes per experiment 
while  the  genotyping  microarrays  presented  in  Articles  Two  and  Three  can 
simultaneously  measure  approximately  five  hundred  thousand  target  genetic 
markers per experiment.
Despite the differences between expression and genotyping microarrays, 
they share several notable similarities with most other types of microarrays. The 
first similarity is the requirement for data normalization. If the values measured on 
one  microarray  are  to  be  compared  to  the  values  measured  on  another 
microarray,  the  microarrays  must  be  normalized  to  each  other11,12.  This  is 
accomplished by a systematic adjustment of the magnitude of measured values 
with  the  intention  of  removing  unwanted  variation  introduced  by  experimental 
conditions  (covered  in  more  detail  in  the  bioinformatics  section  of  the 
Introduction).  Another feature that all  microarrays have in common is the large 
number of observations generated per experiment. This is both an advantage and 
a  disadvantage.  It  is  a  disadvantage  because  the  problem of  false  discovery 
becomes  much  more  prominent.  High  numbers  of  false  discoveries  are 
unavoidable  when  large  numbers  of  statistical  tests  are  applied.  However, 
because  microarrays  are  so  efficient  in  collecting  many  observations 
simultaneously, this reduces cost and increases the speed at which experiments 
can  be  performed,  opening  new  possibilities  for  data  analysis  (such  as  the 
dimension  reduction  techniques  presented  in  the  bioinformatics  section  of  the 
Introduction). 
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Population Genetics – The European Human Population
All of the articles in this thesis deal with the European human population 
either  directly  or  indirectly.  Article  two  in  particular  focuses  on  the  population 
genetic structure of Europe, while the other articles use data derived from the 
European population. A brief overview of population genetic studies in general and 
the chronology of studies on the Europeans specifically will assist the reader in 
placing the work presented here into the broader context of previous knowledge. 
Genetic  structure  is  the  term  used  to  describe  the  uneven  geographical 
distribution  of  alleles  from  one  or  more  genes  within  a  population.  Genetic 
structure can be observed at the level of individual genetic markers as a dynamic 
phenomenon,  changing  over  time  under  the  influence  of  four  driving  factors: 
migration, selection, mutation, and genetic drift13. Genes may be located in close 
physical proximity to each other on the genome. In this case, changes in genetic 
structure observed at one genetic locus is not independent of changes observed 
at the other locus because the loci are physically  linked. The linkage observed 
between markers is directly correlated with their physical proximity. All of these 
factors combine to produce intricate and dynamic patterns of  genetic  variation 
over a geographic range. Documenting and interpreting these patterns is the core 
focus of this research.
The  first  comprehensive  study  of  European  human  population  genetic 
structure  was done in  the  late  1970's  by a group lead  by Luigi  Luca  Cavalli-
Sforza14. The study's methodology was groundbreaking on two accounts. First, it 
was the first  Europe-wide study that  examined a large number  of  genetic  loci 
(n=38) and second, it used multivariate principal components analysis (PCA) to 
generate maps depicting genetic gradients across the continent. Most of the loci in 
this early study were blood groups and HLA (human lymphocyte antigens). These 
loci are very informative because of their high levels of polymorphism. The study 
reported a primary  southeast-northwest  genetic  gradient  across Europe,  which 
was hypothesized to correspond with the neolithic expansion of agriculture from 
the  Middle  East.  This  primary  gradient  has  since  been  repeatedly  verified15,16. 
Beside  the  primary  principal  component,  other  principal  components  revealed 
genetic gradients across Europe in various directions, although explanations for 
these gradients were more tenuous. By the early 1990's, technological advances 
and the discovery of  new genetic  markers  brought  the number  of  genetic  loci 
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examined in Europe to over one hundred, including more HLA alleles as well as 
allozymes (enzyme variants), immunoglobulin variants, and DNA polymorphisms. 
In addition to the previously used multivariate analysis methods such as PCA and 
multidimensional scaling (MDS), data were analyzed using spatial autocorrelation 
and  clustering  methods,  recognized  as  being  useful  on  hierarchical  data.  A 
comprehensive review showed inconsistent  clustering of  European populations 
and genetic  gradients  in  a  variety  of  directions  across the continent,  although 
predominantly  southeast-northwest17.  The  main  conclusions  drawn  by  these 
studies  were  the  existence  of  genetic  associations  between  geography  and 
language and a complex migration history evidenced by inconsistent patterns of 
clusters and gradients. Little evidence for selection was noted although there was 
speculation  that  future  methods  may  discover  variation  related  to  north-south 
differences  in  physical  traits.  (An  example  of  selection  is  presented  in  the 
Additional Results portion of this thesis,  Evidence of Selection in OCA2/HERC2 
and  LCT  Genes).  Throughout  the  1990's  and  into  the  new  century  the 
advancement  of  DNA analysis  techniques  brought  with  it  an  increase  in  the 
number of studies using mitochondrial DNA (mtDNA) and Y-chromosomal markers 
which shed further light on the population structure in Europe18. Data derived from 
Y-chromosome  markers  reaffirmed  the  genetic  gradient  indicative  of  neolithic 
expansion  from  the  Middle  East,  but  interestingly  did  not  show  significant 
association  with  language.  In  contrast, mtDNA  markers  were  more  evenly 
distributed and showed a weaker neolithic genetic gradient than was observed in 
previous studies. This and further evidence lead to the hypothesis that  human 
males are more sedentary than human females19.
In  the  late  1990's,  commercial  microarray  technology  became  widely 
available enabling cost effective SNP genotyping of unprecedented numbers of 
markers10 and population geneticist began using these autosomal genetic markers 
in studies. In 2006, a major development in the analysis of autosomal SNP marker 
data was made which allowed PCA analysis to be done using individuals as the 
unit  of  measurement20.  This  was  a  significant  improvement  over  the  previous 
method  where  genetic  distance  measures  were  based  on  allele  frequencies 
estimated  from populations  because  1)  the  accuracy  of  such  allele  frequency 
estimations  are  very  sensitive  to  sample  size  and 2)  the  definition  of  a priori 
populations  can be problematic. These two developments led to several studies 
(one example is included as Article Two of this thesis) which combined aspects of 
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the fields of  biotechnology and population genetics to add further detail  to the 
understanding  of  European population  genetic  structure16,21-23.  Results  of  these 
population genetic studies have an obvious application in genetic epidemiology 
where population structure is referred to as  stratification and has been a major 
concern of researchers during the past quarter century. 
Genetic Epidemiology - Genetic Association Studies and Genetic Matching
Discovering the  genetic  causes of  human diseases is  a  major  focus  of 
biomedical research. This endeavor is complicated by many factors which, taken 
together,  obscure  the  causal  link  between  genes  and  disease.  The  use  of 
statistical analysis and the development of designs to maximize the experimental 
power have therefore become an important area of research in the biological and 
medical sciences.
With  the  formulation  of  the  modern  theory  of  genetics  in  the  late  19th 
century,  Gregor  Mendel  provided  a  mechanism  for  explaining  how  heritable 
diseases are transmitted24. Diseases which can be accurately explained by this 
model  are  called  simple  monogenic  diseases  (controlled  by  a  single  gene). 
Because they are easily identified by their characteristic pattern of transmission, 
more  than  fifteen  thousand  of  these  simple  diseases  have  so  far  been 
characterized25,  many  of  them  associated  with  the  disruption  of  metabolic 
pathways.  However,  although  simple  diseases  are  numerous  they  are  the 
exception  among diseases,  occurring  in  very  few individuals  in  the  population 
because the alleles causing these diseases are rare. This observation is a direct 
result  of  their  straightforward  mechanism of  transmission  which  allows  natural 
selection to act as a strong force to reduce the frequency of the disease in the 
population.  The  simple  model  of  a  single  genetic  marker  displaying  either 
dominant  or  recessive  inheritance  presented  in  biology  textbooks  belies  the 
complexity faced by researchers when examining genetic diseases. Most common 
diseases  (i.e.  coronary  heart  disease26,  Alzheimer’s  disease27 and  Parkinson’s 
disease28) occur at high frequencies in the human population despite the large 
financial  and  scientific  investment  by  both  academic  researchers  and 
pharmaceutical companies in combating these diseases. These diseases do not 
display the characteristic patterns of transmission that allow explanation by the 
simple  Mendelian  model  of  monogenetic  inheritance.  For  this  reason,  these 
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diseases are called complex, however, it must be kept in mind that diseases do 
not necessarily have to have a genetic component; they may be caused entirely 
by environmental factors.
Complex diseases are defined as those which are not easily explained by 
the simple Mendelian model of monogenic inheritance but still have some genetic 
component.  Many  factors  can  obscure  the  patterns  of  transmission  expected 
under the simple model, thus leading them to be classified as complex diseases29. 
1) A disease may be caused by several genes (epistasis). In this case, disease 
inheritance is no longer a straightforward matter but depends upon the sum total 
contribution  of  many  alleles  at  many  genetic  loci.  Because  of  genetic 
recombination  that  takes  place  during  meiosis,  the  exact  genetic  composition 
causing the disease is unlikely to be passed on in the same state to the offspring. 
This makes observation of the inheritance pattern of the disease difficult. 2) The 
presence of a disease allele may result in varying degrees of manifestation of a 
disease in different individuals (penetrance). It may even be the case that some 
individuals carrying a disease gene are completely unaffected by the disease. 3) 
In  some  cases,  several  different  genes  may  cause  the  same  or  very  similar 
diseases  (multigenic  causes  and  genetic  heterogeneity)  4)  There  are  some 
diseases which, although autosomal, are inherited only maternally or paternally 
(imprinting).  Finally,  5)  Many  diseases  are  also  strongly  influenced  by 
environmental  effects  that  obscure  patterns  of  inheritance  in  genetic  studies. 
Compounding the matter, each of the confounding factors mentioned above may 
be acting in the presence of one or more of the others. It may be of interest here 
to mention a class of simple diseases which is expressed with a phenotype very 
similar to particular complex diseases. These rare monogenic forms have been 
very important in helping understand the disease process than have their more 
common complex disease counterparts because the genetics of the monogenic 
forms are more easily understood.
A comparison summarizing the main features of each disease category.
Table2. Simple vs Complex Diseases
Simple Diseases Complex Diseases
Genetic Model
Influence of Selection Strong Weak
Frequency in Population Rare Common
Confounding Factors Few or none Many
Gene Detection Easier Very Difficult
Monogenic Polygenic
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Different  methods  have  been  developed  to  identify  disease  causing  (or 
disease  associated)  genes  despite  the  confounding  factors  found  in 
epidemiological data. Traditionally, genetic epidemiological studies have employed 
well-ordered  series  of  analyses  which  were  applied  in  sequence.  However, 
analyses have become less structured today. The first analysis which should be 
done for  any  disease  being  studied  is  a  confirmation  of  the  diseases  genetic 
component. This can be done for example by comparing the recurrence risk of 
disease in affected families versus the general population risk, or by examining 
disease  co-occurrence  in  monozygotic  over  dizygotic  twins  to  estimate  the 
heritable component of the phenotype in question. Once the disease has been 
shown to have a genetic component,  segregation analysis30 can determine the 
inheritance pattern of the disease by examining co-transmission of phenotypic and 
genotypic  traits  within  pedigrees.  In  studies  of  human  diseases,  segregation 
analysis  is  a  data  intensive  process  that  requires  analysis  of  pedigree  and 
phenotypic data from as many families affected by the disease as possible. The 
analysis described up to this point is done without having to collect any genotype 
data. After the mode of inheritance has been determined by segregation analysis, 
linkage  analysis  is  used  to  identify  the  location  of  the  disease  gene  on  the 
genome. Linkage studies31 are usually performed on familial data, but can also be 
performed on population-based data. In familial linkage analysis, the transmission 
of  the  disease  phenotype  together  with  alleles  of  markers  of  known genomic 
positions are observed to identify markers which are physically close, or 'linked', to 
the  disease  causing  gene.  Once  linkage  has  been  identified,  a  focused 
genotyping effort is made using additional genetic markers in the region of interest 
and an association analysis32 is performed to identify alleles co-occurring with the 
disease  at  the  population  level.  Association  analyses  therefore  typically  use 
population-based  data,  but  they  can  also  be  performed  using  familial  data. 
Because microarray technology has drastically lowered the cost of genotyping, the 
investment in segregation analysis and even linkage analysis is often dispensed 
with in favor of simply performing association testing on genome-wide scans of 
population-based samples. It should also be noted that in the context of genome-
wide  scans,  family-based  linkage  studies  and  population-based  association 
studies have differing detection sensitivities, the former on rare alleles with weak 
effects and the latter on common alleles with strong effects.
One weakness in  population-based case-control  studies,  is  the possible 
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presence of either population genetic structure (see Introduction, Section Two), or 
stratification  of  the  sampled  population,  which  can  both  lead  to  spurious 
results33,34. The most dramatic example would be a situation where the 'cases' and 
'controls' come from two different populations. If this were the case, it is possible 
that the genetic differences seen between cases and controls are due entirely to 
population genetic differences, and not at all related to the disease state. When 
this problem became a matter of concern in the genetic epidemiology community 
in the 1980's, researchers developed two strategies to respond to it. One was to 
focus  on  family-based  association  analysis,  using  core  families  as  the 
experimental unit35. The analysis examines the transmission of marker alleles and 
looks at the correlation between these transmission events and the transmission 
of the disease. Family-based association analysis is not affected by population 
structure because the observation of  transmission events does not depend on 
population allele frequencies in the families tested. Another strategy to deal with 
population stratification in association studies was to measure its magnitude and 
to adjust for it  appropriately when conducting the statistical test for association 
using  two  methods:  1)  the  genomic  controls  method36,  which  adjusts  the  test 
statistic according to an inflation factor estimated from control  markers located 
throughout the genome, and 2) the structured association method37,  which first 
tests for the presence of structure in the sampled population and then stratifies the 
analysis  according  to  the  observed  structure.  Both  methods  were  developed 
before  microarray  technology  spawned  the  massive  genome-wide  screening 
projects  sponsored  by  the  British  Wellcome  Trust38,  the  American  National 
Institutes of Health39 (NIH), and the German Nationales Genomforschungsnetz40,41 
(NGFN)  in  a  wide  range  of  complex  diseases such  as  diabetes42,  arthritis43,44, 
Crohn's  disease45,  Sarciodosis46,  gallstone  disorders47,  Parkinson's  disease48, 
periodontitis49, coronary heart disease50, bipolar disorder51 and hypertension52.
One of  the criticisms raised against  genome-wide association studies is 
that the number of false positives is high, which is an unavoidable side effect of 
the massive numbers of  genetic  markers  screened by microarrays.  This casts 
some doubt on the validity and replicability of studies using this method53. Partly in 
response to this line of criticism, the main topic of the third article is an evaluation 
of genetic-matched pair study design. This study design is an alternative to the 
association  tests  usually  performed  in  genome-wide  association  studies  and 
reduces  the  potential  for  false  positive  results  by  restricting  the  statistical 
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comparisons to genetically similar pairs of cases and controls.
Functional Genomics – Gene Expression
The development of high-throughput genotyping technology at the end of 
the 20th century led soon after to the complete sequencing of the human genome 
and stimulated further interest in the field of functional genomics. Simply defined, 
functional genomics is the study of how genes work54. It encompasses all aspects 
of  molecular  biology's  central  dogma  (see  Introduction,  Biotechnology)  and 
includes study of the entire spectrum of mechanisms and processes that control 
and influence transcription and translation. Functional genomics covers, among 
other areas, comparative sequence analysis both between genes and between 
species,  protein  analysis  including  protein  sequencing  and  protein  structure 
analyses, aspects of molecular phylogeny and evolution, and research into mRNA 
splice variants. Although functional genomics is a broad field of study, the focus 
for purposes of this introduction will be on gene expression55. Gene expression is 
measured  from  mRNA extracted  from  cells  or  tissue  of  interest  and  reverse 
transcribed to cDNA to facilitate quantification using microarrays (see Introduction, 
Section  One).  The principle  advantage of  using expression  microarrays  is  the 
large number of gene expression levels that can be measured simultaneously in a 
single  experiment.  Typical  gene  expression  studies  involve  comparing  gene 
expression  levels  from  two  or  more  different  sources  with  the  intention  of 
measuring  differences  of  biological  interest.  The  scientific  question  dictates 
whether  the  comparisons  made  are  between  different  tissue  types,  between 
treatment  and  control  samples,  diseased  or  healthy  organs,  or  from  a 
developmental time series, for example. However, even before comparisons are 
considered,  interesting  observations  can  be  made  about  the  mathematical 
distribution of expression levels, which is a topic of scientific interest in its own 
right. It was observed early on that the expression levels did not follow a Poisson 
distribution; however studies on the distribution of expression levels in microarrays 
gave  conflicting  descriptions  of  the  underlying  mathematical  function.  Some 
researchers observed a power-law distribution56,  and others a log-normal57 or a 
skewed  binomial  differential  distribution58.  In  Article  One  of  this  thesis,  the 
distribution of gene expression levels in the microarray system we examined is 
shown  to  follow  Zipf's  Law  and  this  observation  is  further  developed  into  a 
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normalization  method  for  between-array  comparisons  and  functionally  specific 
microarrays. These microarrays are also known as boutique microarrays because 
they contain a selected set of functionally specific expression targets making them 
unsuitable for global normalization or the standard Quantile method. Additionally, 
the normalization method presented here found practical implementation in three 
gene expression studies59-61.
Bioinformatics – Data Normalization
Bioinformatics,  the  use  of  computer  science  or  informatics  to  develop 
techniques and procedures for handling and analyzing biological data, includes 
topics ranging from mundane data management software to the development of 
complex algorithms for  sequence alignment  or  protein conformation prediction. 
Technological advances in both the fields of biology and computer science have 
increased the scale and speed of  experimental  data collection to a heretofore 
unprecedented level. Historically, extremely large data sets have been available to 
biologists  only  through long,  labor  intensive data collection.  Currently,  it  is  not 
uncommon  for  biologists  to  collect  millions  of  experimental  observations  in  a 
single day making it necessary for biologists to manage datasets as large or larger 
than  those  previously  dealt  with  in  such  disciplines  as  physics,  chemistry, 
astronomy, and economics. 
While it may seem that biologists are following in the footsteps of others by 
borrowing  analytical  methods  from  different  fields  to  analyze  large  data  sets, 
history shows that many of these methods were originally developed for use with 
biological data. For example, principle components analysis is one such method 
featured in Article Two of this work. This mathematical technique, which reduces 
the number of variables while minimizing the loss of information in a dataset, has 
for many years been put to extensive use in fields outside biology, although it was 
developed in 1901 by Karl Pearson for use in biology among other applications62. 
Another  analytical  method  often  used  in  population  genetic  and  functional 
genomic studies is clustering. Cluster analysis traces its early development to the 
field  of  taxonomy  which  involves  conceptually  grouping  species  according  to 
characteristics  in  a  hierarchical  fashion.  In  the  1960's  taxonomists  developed 
hierarchical clustering as a method for grouping species in an unbiased manner 
and  participated  in  the  founding  of  the  Classification  Society63.  Hierarchical 
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clustering is compared to principal components analysis in the additional results 
section of  this  thesis.  The application of  ordination methods which reduce the 
dimensionality of data to make them effectively more manageable (i.e. principal 
components analysis) and hierarchical clustering for grouping data represents an 
important  emergent  feature  of  large  data  sets  as  these  methods  make 
observations possible which are not attainable with smaller data sets.
Data  normalization  is  an  important  bioinformatic  technique  which  is  the 
major  theme  of  Article  One.  Data  normalization  is  the  removal  of  undesired 
systematic variation from a dataset to facilitate statistical comparison. Variation in 
biological  data can arise from many sources, not  all  of which are undesirable. 
Indeed  the  objective  of  all  biological  research  is  to  draw  conclusions  about 
biological phenomena by measuring variation generated from biological sources 
despite confounding variation from unwanted sources. Sources of variation can be 
either systematic (affecting portions of the data in a predictable way) or stochastic. 
Systematic  variation  can  sometimes  be  removed  using  correction  factors 
estimated  from the  data  itself  without  the  necessity  and  expense  of  replicate 
sampling. The removal of systematic variation to facilitate data set comparisons is 
termed “normalization”. With the advent of microarray technology, one early area 
of  intense  research  was  in  the  application  and  optimization  of  normalization 
methods11,12.  In  expression  microarrays  (see  also  Introduction,  Section  One), 
systematic variation can arise from several sources. For example, differences in 
target  DNA concentrations  between  spots  during  microarray  manufacture,  or 
uneven application of probe DNA in the experiment phase can cause within-array 
variation. Between-array variation can be caused by differences in exposure times 
of probes to the microarray, or differences in RNA extraction efficiency from the 
tissue.  Article  One  proposes  a  between-array  normalization  based  on  the 
observation that gene expression levels follow a distinct mathematical distribution 
(see also Introduction Section Four). Algorithms for normalization of expression 
microarrays can be divided into three classes of methods: global, intensity-based, 
and location-based. The global methods were the first proposed and also the most 
primitive of the between-array normalization methods, which adjust all arrays to 
the same mean and standard deviation. However, these simple methods often led 
to  unsatisfactory  results.  Later  methods  were  therefore  developed  having 
normalization  factors  dependent  on  the  intensity  of  the  expression  signal 
(quantile-quantile  method,  Loess  curve  fitting).  In  their  most  simple 
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implementation,  correction  factors  used in  both  the  global  and  intensity-based 
normalization methods are derived from the entire spectrum of measured gene 
expression levels. A variation on these methods derives the correction factor from 
a  subset  of  data,  either  reference  samples  placed  on  the  microarray  for  the 
purpose of normalization or so-called 'housekeeping genes'. Housekeeping genes 
are usually constitutive proteins, responsible for essential cell functions, which are 
assumed to be unaffected by experimental treatments and thus expressed at a 
consistent  level  between  microarrays.  The  motivation  for  using  housekeeping 
genes as  the benchmark  for  normalization  is  that  they are less  influenced by 
extreme  measurements  and  produce  more  consistent  correction  factors.  This 
topic is further elaborated in Article One. The work presented in Article One was 
completed  between  2000  and  2003,  and  reflects  the  state  of  knowledge  and 
technology at that time. Many of the concepts developed for the normalization of 
expression microarrays are equally applicable to the genotyping microarrays that 
became  first  commercially  available  between  2003  (Affymetrix)  and  2005 
(Illumina).
Synopsis
The  preceding  five  summaries  of  broad  research  areas  provide  a 
background  for  understanding  the  three  articles  that  follow.  Each  of  the  three 
articles, in turn, integrates aspects of three research areas (Figure 1). Article One 
Figure 1. Integrated Areas 
of Research: A diagram 
putting the articles 
presented in this thesis 
(white text, One, Two, and 
Three) into the context of 
broader fields of biological 
research (colored circles).
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integrates biotechnology,  functional  genomics,  and bioinformatics  by examining 
the nature of the distribution of gene expression levels measured in microarray 
experiments.  The  distributions  are  found  to  belong  to  a  family  of  long-tailed 
distributions (power-law and log-normal distributions). This observation motivates 
the  development  of  a  normalization  method  which  is  evaluated  against  other 
available normalization methods. Article Two presents research in the overlapping 
fields  of  biotechnology,  bioinformatics  and  population  genetics.  In  this  study, 
principal  components  analysis  is  applied  to  a  large  microarray  generated 
genotype data set from the European human population to examine population 
genetic  structure.  Despite  low  levels  of  genetic  differentiation  between 
subpopulations,  a  strong  continent-wide  correlation  between  geographic  and 
genetic distance is observed. Also, a widely used group of control sampled (the 
CEPH Caucasian individuals from Utah) are mapped onto the European genetic 
landscape.  Article  Three combines biotechnology with  population  genetics  and 
genetic  epidemiology  by  making  observations  on  genetic  similarity  in  the 
European population based on the same microarray genotype data used in the 
previous  study.  The  structure  of  genetic  relatedness  between  European 
individuals  is  examined  and  a  genetic  matching  study  design  to  increase  the 
power of genetic association studies is proposed. A marker set designed to be 
useful in identifying the 'best' genetic-matching pairs is ascertained and evaluated.
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Article 1
Can Zipf's law be adapted to normalize microarrays?
This article has been previously published as:
Lu,  et.  al.  Can  Zipf's  law  be  adapted  to  normalize  microarrays?  BMC 
Bioinformatics. 2005 ;6:37.
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Abstract
Background: Normalization is the process of removing non-biological sources of variation
between array experiments. Recent investigations of data in gene expression databases for varying
organisms and tissues have shown that the majority of expressed genes exhibit a power-law
distribution with an exponent close to -1 (i.e. obey Zipf's law). Based on the observation that our
single channel and two channel microarray data sets also followed a power-law distribution, we
were motivated to develop a normalization method based on this law, and examine how it
compares with existing published techniques. A computationally simple and intuitively appealing
technique based on this observation is presented.
Results: Using pairwise comparisons using MA plots (log ratio vs. log intensity), we compared this
novel method to previously published normalization techniques, namely global normalization to the
mean, the quantile method, and a variation on the loess normalization method designed specifically
for boutique microarrays. Results indicated that, for single channel microarrays, the quantile
method was superior with regard to eliminating intensity-dependent effects (banana curves), but
Zipf's law normalization does minimize this effect by rotating the data distribution such that the
maximal number of data points lie on the zero of the log ratio axis. For two channel boutique
microarrays, the Zipf's law normalizations performed as well as, or better than existing techniques.
Conclusion: Zipf's law normalization is a useful tool where the Quantile method cannot be
applied, as is the case with microarrays containing functionally specific gene sets (boutique arrays).
Background
DNA microarrays have become a widely used biotechnol-
ogy for assessing expression levels of tens of thousands of
genes simultaneously in a single experiment [1,2].
Whether microarrays are being used for global tissue pro-
filing or for differential expression studies, data normali-
zation is an essential preliminary step before statistical
analysis methods can be applied. The purpose of all nor-
malization techniques is to transform the data to elimi-
nate sources of variability stemming from experimental
conditions, leaving only biologically relevant differences
in gene expression for subsequent analysis. Normaliza-
tion can be divided into two stages, intra-array normaliza-
tion and inter-array normalization. Intra-array
normalization deals with variability within a single array
caused by factors such as differences in print-tip
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characteristics, channel differences in two-dye systems,
and spatial heterogeneity across the array surface [3-5]
and should be carried out using accepted methods before
inter-array normalization is applied. This paper assumes
intra-array normalization has been performed and
presents an inter-array normalization method for compar-
ison of gene intensity levels between multiple microarrays
to deal with variation caused by such factors as differences
in RNA isolation efficiency, labeling efficiency, hybridiza-
tion conditions, exposure times, and detection
efficiencies.
It is now clear that simple inter-array normalization tech-
niques, such as simple scaling to housekeeping genes or
normalizing to a global mean, are not adequate for micro-
array data [6]. Housekeeping genes have been found to be
more susceptible to modulation than previously thought
[7]. Along with others [5], this paper underscores the
potentially serious drawbacks of the global mean and
other such methods. Recent literature has thus provided a
plethora of more sophisticated normalization and analy-
sis techniques as researchers struggle to cope with the task
of microarray data analysis, some of which include maxi-
mum likelihood analysis [5], centralization [6], principal
component analysis [8], analysis of variance [9] and Baye-
sian network analysis [10].
Analysis of publicly available large-scale SAGE gene
expression data sets [11,12] and an intra-phyletic survey
of genome wide Affymetrix microarray experiments [13]
have indicated that the large majority of expressed genes
exhibited power-law distributions, while some microarray
expression data exhibit a more log-normal distribution
[14]. Our normalization procedure was inspired by the
observation that the intensities measured on our microar-
ray system also followed a power law distribution and can
therefore be described by a simple mathematical model.
Zipf's law [15] is a power law function that states that the
magnitude of an intensity measurement (y) is inversely
proportional to the rank (r) of that data point in the data
set,
y∝rc  (1)
where c is a coefficient close to -1. Our microarray data can
be classified as a generalized form of Zipf's law because
the coefficient (c) is not always close to -1 and, in fact, var-
ies between individual microarrays, making simple linear
normalization procedures, such as global normalization
to the same mean, inappropriate. However, the normali-
zation procedure proposed here demonstrates that by tak-
ing Zipf's law into account, it is possible to apply a simple
intra-array normalization procedure such that all filters
have the same coefficient c and proportionality.
We demonstrate the Zipf's law based normalization tech-
nique on microarray data sets representing both single
channel and two channel technologies. In the single chan-
nel category, we produced two radio-labeled, nylon mem-
brane based cDNA data sets, one commercial and one
generated "in-house". Both systems contain a selection of
genes chosen without regard to functional or pathway
considerations, which make them especially appropriate
for normalization using Zipf's law. These data sets were
also normalized to a global mean (the mean of all micro-
arrays) [16], and the quantile normalization method [17].
In addition we produced a two channel, fluorescently
labeled, glass slide, oligo-based microarray data set gener-
ated 'in-house'. This microarray can be classified as a 'bou-
tique' microarray because it consists of a selection of genes
involved in apoptosis. This data set was normalized with
a variant of the Zipf's law normalization method that uses
a subset of the distribution as a proxy for normalizing the
entire microarray. A comparison was then conducted
against a variant of the loess normalization method that
uses an a priori selection of 'housekeeping' genes as a
proxy for normalization.
The finding that our microarray data distributions con-
form to a power law distribution agrees with predictions
based on genome wide gene expression studies [11-13],
however Hoyle, et. al. [14] observed that microarray dis-
tributions were log normally distributed with possible
power law tails. To investigate this discrepancy, and to ver-
ify that our normalization technique could be useful in
the normalization of data sets from other microarray sys-
tems, we also surveyed publicly available data sets from
the NCBI Gene Expression Omnibus [18].
The two assumptions upon which the normalization
method are based are the same as those used in other nor-
malization methods [5,6], namely that in comparisons
between similar tissues or cell lines under different exper-
imental conditions i) most genes are not, or only moder-
ately, regulated, and ii) approximately equal numbers of
genes are up regulated as down regulated. Systems which
conform to these two assumptions will be referred to as
'well-behaved' in this paper. While these assumptions
probably hold for microarrays derived from a diverse sam-
pling of genes, for example an EST library survey, they
may not hold for microarrays containing genes specifi-
cally selected based on function or pathway (so called
'boutique' microarrays) as it is likely that most genes will
be affected by the experimental treatments. One way to
circumvent the restrictions resulting from these assump-
tions is to use a subset of data, or proxy, from the bou-
tique array data set which fulfils the 'well-behaved'
criteria. In developing a boutique microarray normaliza-
tion technique, Wilson et. al. [4] have devised a method
for selecting a subset of genes within a microarray data set
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that have low variation between arrays and are well repre-
sentative of the spectrum of intensities measured on the
microarray. They term this a priori selected subset 'house-
keeping' genes, however it should not be confused with
the a posteriori set of genes typically envisioned when the
term is used. Another possible proxy that could meet the
'well-behaved' criteria are control spots which are
included on the microarray during it's manufacture. We
tested our normalization method on data from a two
channel boutique microarray experiment using two types
of control spots as proxies for normalization (Positive and
negative internal controls, and housekeeping genes). The
Zipf's law normalization methods were then compared
with the variant of the loess method developed by Wilson
et. al. [4] using housekeeping genes.
Results
Verifying Zipf's Law
Before applying the described normalization method, the
adherence of the reference curve (the median gene inten-
sity data versus rank) to Zipf's law was verified. The most
common method of verifying conformity to Zipf's law is a
linear regression on the loge-loge transformed data set.
Our regression showed a good fit, with a correlation coef-
ficient of -0.98 and a slope of -0.56 for microarrays repre-
senting human colon (Figure 1a, Figure 6A, Table 1 set A),
a correlation coefficient of -0.99 and a slope of -0.78 for
rat brain microarrays (Figure 6B, Table 1 set B), and a cor-
relation coefficient of -0.99 and a slope of -0.60 for the
mouse apoptosis microarrays (Figure 6H, Table 1 set H).
It should be noted that while the low ranking intensities
may show a marked deviation from the regression line,
this data typically accounts for a very small proportion of
the total data and does not have a large affect on the
regression curves.
Normalization results – single channel microarrays
A comparison of the Zipf's law normalization method to
the simple method of setting all arrays to a global mean
(the mean of all microarrays) and to the quantile method
was conducted on the single channel microarray data sets.
Five human Unigene microarrays from the panel of thirty-
two microarrays used in the sigmoidal colon experiments
were selected to represent the greatest variability in pre-
normalized data observed in the experiment (Figure 1b).
Normalization to a global mean (Figure 1c) yielded data
sets that displayed a higher variability in the coefficient c
of the Zipf's power function (formula 1) than that
observed after normalization by the Zipf's law method
(Figure 1e) or the quantile method (Figure 1d). The Zipf's
method showed the lowest variation in the Zipf's expo-
nent and had the lowest spread of the data around the
ln(rank) vs. ln(intensity) line. Results of an identical loge
intensity versus loge rank plot comparison in Clontech rat
microarrays showed little difference between the quantile
and Zipf's methods [see Additional file 1]. However it
should be mentioned that this method of data plotting
provides one view of the data which is especially favorable
to the Zipf's law normalization method. Next we examine
the results of the MA-plots, a technique that is especially
favorable to the quantile normalization method.
In order to access the effectiveness of the normalization
method, pairwise comparisons using MA-plots (some-
times called RI plots, or log ratio vs. log mean intensity
plots) [19] were carried out on the raw data, and data nor-
malized with the global mean method, quantile normali-
zation and Zipf's law on both data set A & B (Figure 2 &3
respectively). With the raw data, the distribution of log-
intensity ratios is not centered around zero which is as
expected in an un-normalized data set. There is a noticea-
ble intensity dependent effect, sometimes described as a
'banana' curve, which is characteristic of many microarray
data sets. Normalization with the global mean method
results in a shift of the center of the log-intensity ratio
Unigene microarray log plotsFigure 1
Unigene microarray log plots. Five human Unigene 
microarrays from the panel of thirty-one microarrays used in 
the sigmoidal colon experiments. Upper left to lower right: 
a. Loge median gene intensity vs. loge rank – conformity to 
Zipf's law is demonstrated by the linear regression line (in 
red) b. Five microarrays chosen to maximize pre-normaliza-
tion variability, each plotted according to the gene ranks 
determined by their median gene intensity levels. c. The 
same five microarrays, normalized to a global mean, with 
regression lines. d. The same five microarrays, normalized 
with the quantile method, with regression lines. e. The same 
five microarrays, normalized taking Zipf's law into account, 
with regression lines. For plots b-d, a sub-sample of 10% of 
the data points are plotted for readability.
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distribution closer to zero, one important criterion for
well normalized data, however, especially in the low log
mean range, the bulk of the data points still deviate appre-
ciably from zero. The intensity dependent effect is evident,
with the low intensity end of the loess fit curving away
from the zero axis. The intensity dependent effect is
removed using the quantile method. The log intensity
ratios of the data distributions normalized using Zipf's
law are well centered around zero, but the intensity
dependent effect is still apparent. In this case however, the
bulk of the data lies very close to zero on the log-ratio
scale. [see Additional file 2] This is due to the fact that
Zipf's law normalization not only shifts the data distribu-
tion on the log ratio scale, but also rotates the whole dis-
tribution in log-ratio log-intensity space.
The Kolmogorov-Smirnov test is often used to determine
whether data distributions differ significantly and pro-
vides a test statistic that measures the proportion of over-
lap between distributions which ranges from 0 (in the
case of identical distributions) to 1 (for non-overlapping
distributions) [20]. Mean Kolmogorov-Smirnov values
(Table 2a, b) showed the expected trend, with the high
values for raw, unnormalized data decreasing when global
median normalization was applied, decreasing again after
Zipf's law normalization, and reaching zero for both data
sets under quantile normalization. It should be noted that
the Kolmogorov-Smirnov test statistic will always be zero
after quantile normalization because this method forces
the data distributions of all microarrays to be identical.
Normalization Results – Two Channel Boutique 
Microarray
Plots of loge intensity versus loge rank fitted with linear
regressions show that the Zipf's law normalization based
on internal controls (Figure 4a) and on selected house-
keeping genes (Figure 4c) have relatively similar coeffi-
cients c according to Zipf's power function (formula 1) as
evidenced by the similarity in slopes of the regression
lines. Loess normalization using selected housekeeping
genes (Figure 4b) showed slightly more variation in c
coefficients. The unnormalized raw data is also depicted
(Figure 4d) along with two other normalization results,
the loess method (Figure 4e) and the quantile method
(Figure 4f). These are provided for reference only. Neither
method can be validly applied to boutique arrays because
both rely on the 'well-behaved' genes assumption.
It should be noted that much of the variation in c coeffi-
cients under the various normalization regimes is due to
one channel (Cy3) on one microarray which had low
median intensity and high variance due to low labelling
efficiency (depicted in black in Figure 4). When normal-
ized with the loess techniques (Figure 4c and 4f) the sec-
ond channel (Cy5) on this array is adjusted to have a
similar median intensity and variance, possibly skewing
the results in favour of the Zipf's normalization tech-
niques. To make the normalization method comparison
unbiased, we eliminated this array from the analysis [see
Additional file 3]. The Zipf's normalization based on
internal controls (a) showed the lowest variation in c coef-
ficients, the methods based on selected housekeeping
genes (b, c) performed approximately equally well. Here
again, raw (d), quantile normalized (e), and loess normal-
ized (f) plots are provided for reference only.
Data set comparisonFigur  6
Data set comparison. Eleven microarray data sets (A-K) 
exhibiting varying degrees of conformation to power law and 
log normal distributions. On the left for each data set is a log 
mean intensity vs. log rank plot of the entire data set. Each 
array was sorted independently by intensity, and mean inten-
sities for each rank over all arrays are plotted. A linear 
regression line is shown in red. Data sets with a linear distri-
bution adhere well to a power law distribution. On the right 
for each data set is the distribution (ln(i) – µ) / σ of the mean 
intensities used in the left hand plots, where i is the mean 
measured intensity for each rank and µ and σ are the mean 
and variance of i respectively. The standard normal curve 
N(0,1) is shown in red for comparison. Data sets that display 
a standard normal distribution adhere well to a log normal 
distribution.
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We generated MA plots for each of the normalization
methods we compared (Figure 5). Typically, MA plots are
produced from data from each channel of a single micro-
array. In addition to these 'within-array' plots (the first
three rows of graphs in Figure 5), we also examined
'between-array' plots to evaluate the potential of the nor-
malization methods to allow us to perform across array
comparisons. The Zipf's using internal controls was
slightly more well centered around the zero log ratio axis
than the methods using selected housekeeping genes,
especially in between-array plots. The raw and loess nor-
malized plots are provided for reference only.
Finally, to quantify the differences between distributions
after normalization, pairwise Kolmogorov-Smirnov val-
ues were computed for both the complete boutique array
data set (Table 2c) and after eliminating the array which
contained a low median intensity and high variance due
to low labelling efficiency (Table 2d). In addition to com-
puting the Kolmogorov-Smirnov values for all possible
between-array pairwise combinations, we also summa-
rized just the within-array pairwise comparisons (in
parenthesis in Table 2). Of the normalization methods
which can be applied to boutique microarrays, the Zipf's
method using internal controls produced the most similar
data distributions when all possible between-array com-
Table 1: Data set comparison
Set Microarray Platform Number of 
Data Points
Number of 
Expts
R2 GEO 
platform
GEO 
experiment
Array type
A. Human Unigene RZPD 1 34560 31 0.9877 GLP284 GSE1510 cDNA, membrane
B. Clontech Atlas Rat 
cDNA Expression
588 39 0.9968 GPL158 GSE1509 cDNA, membrane
C. Clontech Atlas Human 
1.2 (I & II)
1176 10 0.9903 GPL127, 
GPL128
GSE751 cDNA, membrane
D. Clontech Atlas Mouse 
1.2
1159 12 0.9460 GPL144 GSE565 cDNA, membrane
E. Clontech Atlas Human 
Cancer 1.2
1160 36 0.9109 GPL158 GSE796 cDNA, membrane
F. NlaIII: Rattus norvegicus 76790 1 0.9982 GPL23 GSM1679 SAGE
G. NlaIII: Homo sapiens 101677 1 0.9978 GPL4 GSM14771 SAGE
H. Mouse Apoptosis 1024 5 × 2 0.994 -- -- cDNA, glass
I. Caltech 16K cDNA 
mouse
908 58 0.8892 na na cDNA, glass
J. Stanford Human Unigene 908 24 0.9081 na na cDNA, glass
K. Affymetrix GeneChip Rat 
Genome
8799 24 0.8538 GPL85 GSE776 Oligo, glass
L. Affymetrix GeneChip 
Human Genome
12625 24 0.7773 GPL91 GSE803 Oligo, glass
Eleven microarray data set comparison. Raw intensities, without background subtraction, were used. Controls and blanks were excluded. For 
Affymetrix chips (K and L), MM/PM ratios were used. For data set B two different Atlas arrays were analyzed together, when analyzed separately 
they gave similar results. For two channel array systems (I and J), each channel was treated as a separate array. For set I, only the cyanine-3 channel 
(spleen sample control) was used and for set J, both channels were used for analysis. Reference for data set J: Ross et. al. [31].
Unigene microarray MA plotsFigure 2
Unigene microarray MA plots. MA plots of Raw Unigene 
data compared to data normalized with the Global mean, 
Zipf's, and Quantile methods (columns). Each row of plots 
represents one pairwise comparison, only 8 of the possible 
10 pairwise comparisons of the 5 microarrays used in figure 
1are shown. Lowess curves are plotted in red.
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Clontech microarray MA plotsFigur  3
Clontech microarray MA plots. MA plots of Raw Clon-
tech Rat data compared to data normalized with the Global 
mean, Zipf's, and Quantile methods (columns). Each row of 
plots represents one pairwise comparison, only 8 of the pos-
sible 10 pairwise comparisons of the 5 microarrays used in 
Additional file 1 are shown. Lowess curves are plotted in red.
Boutique microarray log plotsFigure 4
Boutique microarray log plots. Five mouse apoptosis 
boutique microarrays used in the mouse cell line experi-
ments. Upper left to lower right: Loge median gene intensity 
vs. loge rank – a. Normalized according to Zipf's law, using 
internal positive and negative controls as proxies for the 
whole data set. b. Normalized with a loess curve fit using a 
selected set of housekeeping genes as proxies (see Methods). 
c. Normalized according to Zipf's law, using the same 
selected set of housekeeping genes as in b. as proxies d. The 
raw data. e. For comparison purposes only, normalized using 
the quantile method. f. For comparison purposes only, nor-
malized using the standard loess method.
Table 2: Kolmogorov-Smirnov values
Microarray 
Platform
Pairwise 
Combinations 
(within array)
Raw Global 
Median
Zipfs Quantile Loess Loess 
HK
Zipfs 
Control
Zipfs HK
a. Clontech Atlas 
Rat cDNA 
Expression
465 0.539 0.484 0.119 0 na na na na
b. Human Unigene 
RZPD 1
703 0.662 0.225 0.060 0 na na na na
c. Mouse 
Apoptosis
45 (5) 0.548 
(0.631)
0.340 
(0.318)
0.149 
(0.167)
0 (0) 0.471 
(0.042)
0.487 
(0.172)
0.182 
(0.179)
0.303 
(0.296)
d. Mouse 
Apoptosis 
Subset
28 (4) 0.568 
(0.667)
0.303 
(0.287)
0.111 
(0.129)
0 (0) 0.317 
(0.038)
0.341 
(0.190)
0.145 
(0.128)
0.315 
(0.291)
Three microarray data sets presented in this paper and seven normalization techniques were compared by computing the mean Kolmogorov-
Smirnov values of all possible pairwise combinations of arrays within a data set. In the case of the two channel mouse apoptosis microarray, within-
array pairwise comparisons were also computed and are shown in parenthesis (here n = the number of arrays, as each array has 2 channels). The 
symbol 'na' indicates that the normalization techniques which can only be carried out on two channel (loess) or boutique (loess HK, Zipfs Control, 
Zipfs HK) arrays were not performed on single channel arrays. Values in bold typeface were computed for reference purposes only – these 
normalization methods cannot be validly applied to boutique microarrays.
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6, data sets A-E) and log normal distributions (Figure 6,
data sets I-K). Of the six power law data sets, two (B and
C) clearly followed Zipf's law distributions. The remain-
ing four (data sets A, D, E, and H), while still power-law
distributed, showing noticeable deviations from the dis-
tribution at the lower rank (higher intensity) portion of
the distribution. Of the platforms that where recognizably
log normal in distribution, two fluorescent dye labeled,
oligo-based Affymetrics platforms (data sets K and L) fol-
lowed the distribution most closely and two dye labeled,
cDNA systems (data sets I and J) were perceptibly log nor-
mal. The two SAGE experiments (data sets F and G) which
Boutique microarray MA plotsFigure 5
Boutique microarray MA plots. MA plots of the boutique data set comparing (in columns) Zipf's normalization using con-
trols (Zipfs), Zipf's normalization using housekeepers (Zipfs HK), loess normalization using housekeepers (loess HK), raw data, 
and, for comparison purposes only, the standard loess normalization. Each row of plots represents one pairwise comparison, 
only 6 of the possible 45 pairwise comparisons of the 5 microarrays used in figure 4 are shown. The top three rows show 
within-array comparisons, and the bottom three rows show between-array comparisons. Lowess curves are plotted in red.
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were included for comparison purposes, exhibited Zipf's
law distributions. Coefficients of determination (r2) of the
log mean intensity vs. log rank are a measure of conforma-
tion to a power-law distribution and ranged from 0.9968
to 0.7773 for microarray data sets, 0.9982 and 0.9978 for
the SAGE experiments (Table 1).
Discussion
Zipf's law is based on observations made by linguist
George Kingsley Zipf that the frequency of word occur-
rences in natural languages is proportional to the negative
power of the rank order of the word. Beside the original
findings in natural languages [15], Zipf's law has been
found to apply to a plethora of natural phenomena, from
the populations of cities to the impact factors of scientific
journals as well as a variety of biological data, of which a
review made available by Wentian Li [21] is an excellent
online resource. It is important to point out, that being a
phenomenological principle, Zipf's law does not imply
that there is a universal underlying physical process at
work. However, in much the same way that the Gaussian-
Normal distribution occurs naturally in data and can be
used to statistically test or otherwise manipulate the data,
the fact that microarray data conforms to Zipf's law can be
adapted for the purpose of microarray normalization.
Zipf's law is a power law function that states that the mag-
nitude of an intensity measurement is inversely propor-
tional to the rank of that data point in the data set, where
c is a coefficient close to -1. Ranking is a method common
in statistics, which has previously been used to analyze
microarray data. Hoyle el. al. [14] used ranking as a
method for evaluating microarray data and proposed the
use of several statistics including χ2 to quantify the agree-
ment of the distribution to Benford's Law [22], and σ2 as
a quality control measure to detect such factors as low sig-
nal to background ratio, or mRNA probes extracted from
mixed cell types. Ranking also figured prominently in the
evaluation of a survey of inter-array normalization meth-
ods [23] where the statistics 'absolute rank deviation' and
'relative rank deviation' were used to select the method
that produces the most 'well-normalized' data. The nor-
malization procedure described in this paper is the first to
combine these two ideas, namely that ranking can be used
to judge the effectiveness of a normalization method, and
that microarray data conforms to Zipf's law. We evolved
these ideas into a novel and easily applicable normaliza-
tion method and compared this method with existing
methods to eliminate non-biological variation from
microarray data sets.
In order to implement an appropriate data normalization
technique, it is important to know the distribution of a
given data set. Several publications have examined the
data distributions that typically result from microarray
experiments. In a survey of seventeen microarray data sets,
sixteen of which were fluorescent dye labeled, Hoyle et. al.
[14] reported that microarray data were found to have a
log normal distributions with power law tails. More recent
publications have reported that the abundance of
expressed genes exhibit power-law distributions
[11,13,24]. Results from our own data sets and a subse-
quent survey of publicly available data sets from both
radioactively and fluorescently labeled platforms suggest
that both types of distributions can be manifested in
microarray data.
Comparisons between the Zipf's law and quantile nor-
malization methods using MA plots showed that the
quantile method effectively removes intensity dependant
effects, sometimes referred to as 'banana' curves, from
microarray data sets, while the Zipf's law method has no
effect on the curved nature of the intensity dependent
effect. This is not altogether unexpected as the quantile
method was specifically designed to remove such effects.
While the Zipf's method does not remove the curve from
the intensity dependent effect, it does minimize negative
consequences by rotating the data distribution such that
the maximal number of data points lie on the zero of the
log ratio axis. In this respect, the Zipf's law normalization
technique can be considered inferior to the quantile
method, however, it may still be a useful tool where the
quantile method cannot be applied.
One such case, in which quantile normalization is inap-
propriate, is with so called 'boutique' microarrays where
the genes spotted on the array represent a selected set of
genes, for example from a specific pathway or those
involved with a particular biological process or disease
state. In such systems, most genes are expected to be
differentially regulated when control and experimental
samples are compared and the expected data distribution
of control samples may be significantly different than that
of experimental samples (in mean intensity for example).
The quantile normalization method would effectively
remove this difference by replacing the data distribution
of each microarray with the mean distribution of all
arrays. In contrast, the principle of normalization accord-
ing to Zipf's law can also apply to arrays of this type if a
group of control spots are included on the microarray.
These control spots could be an external reference probe
which hybridises to a concentration gradient of matching
spots on the array, or internal positive (highly expressed
genes) and negative (spotting buffer) control spots on the
microarray, or an a priori selected set of housekeeping
genes using a method such as that described by Wilson et.
al. [4] or Schadt et. al. [25]. A linear model can be fitted to
the control spots alone, and the normalization procedure
can then be applied using the control spots as a proxy for
the entire data distribution. The critical assumption in
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using control spots in normalization is establishing their
relationship to the experimental spots.
The results of our comparison between methods which
are designed to normalize boutique microarray data show
that Zipf's law normalization using internal control spots
results in a relatively well normalized data set when com-
pared to Zipf's law normalization using selected house-
keeping genes and the modified loess method using
selected housekeeping genes. In addition, the Zipf's law
method produced data distributions which are more sim-
ilar between arrays allowing for between-array compari-
sons which are advantageous in terms of both cost,
because of the reduced number of microarrays that need
to be run, and, statistical power, by allowing for greater
numbers (n), experimental design permitting.
Conclusion
In summary, we examined the applicability of using Zipf's
law as the basis for a novel normalization technique,
which is applicable to both one channel microarray data
and two channel microarrays. This method is shown to
out-perform such methods as global normalization to the
mean but would appear to be inferior to quantile normal-
ization. The quantile method was superior to Zipf's law in
removing intensity dependent effects commonly seen in
microarray data. While the latter method cannot be
applied to boutique arrays, we show that the Zipf's nor-
malization method used with internal positive and
negative controls or with selected housekeeping genes
normalizes boutique arrays as well as currently existing
methods. Additionally, data normalized with the Zipf's
method using internal control spots seems more amena-
ble to between-array gene intensity comparisons when
compared to other methods.
Methods
Data acquisition
Data set A (Table 1) was generated using a global genome-
wide cDNA clone set (Human UniGene clone set RZPD 1
Build 138, NCBI [26]), which consisted of ~33,792 cDNA
clone inserts spotted in duplicate onto membranes [16].
These microarrays (n = 31) were hybridized with 33P-
labeled cDNA derived from total RNA extracted from
biopsy material from the sigmoidal colon of normal (con-
trol, n = 11), and patients with Crohn's disease (condition
A, n = 10) and ulcerative colitis (condition B, n = 10). To
emphasize that our normalization technique can be used
to normalize other array systems, the second array set
used was a smaller, but widely used, commercially availa-
ble microarray system. Data set B (Table 1) was generated
by using Atlas Rat cDNA microarrays (Clontech, 588
genes) probed with rat brain tissue, from control (cerebel-
lum n = 10, olive n = 10) and harmaline treated (cerebel-
lum n = 10, olive n = 9) animals. A third microarray data
set, data set H (Table 1) was included to demonstrate the
normalization method on two channel fluorescent based
(Cy3/Cy5) oligonucleotide systems. These custom pro-
duced boutique microarrays (n = 5) contained 1024 spots,
and were used in a study to identify differences in apop-
totic mechanisms in two different mouse cell lines. Micro-
arrays were probed according to established protocols and
exposed to imaging plates overnight (BAS-MS 2325) and
scanned at a 50 µm resolution on a FLA-3000G phos-
phoimager (Raytest, Germany). Image gridding was car-
ried out using VisualGrid® software [27], and intensity
data was stored in a relational database and normalized
and analyzed using database stored procedures and Perl
scripts. All data was normalized from raw data, no back-
ground subtraction or other inter-array normalization was
performed. Plots were generated using the Grace software
package [28].
Normalization
Normalization was accomplished by transforming the
data such that the coefficient c and proportionality of the
Zipf's power function (formula 1) are identical for all
microarrays. This is easily achieved using a regression
model on the loge intensity versus loge rank transformed
data, which has the general form,
ln (y) = a + bln (r) + e  (2)
where y is the intensity, r is the rank, a is the regression
constant (corresponding to proportionality in Zipf's
power function), b is the regression coefficient (corre-
sponding to the coefficient c in Zipf's power function),
and e is an error coefficient, which is assumed to be nor-
mally distributed.
The first step in this three step procedure was to compute
the median intensity of each gene over all microarrays to
establish ranks, which were used as the 'reference' to
which all microarrays were normalized. This was done by
taking the median intensity (ymed) of each gene, over all
microarrays on which it was measured, and sorting the
resulting list of medians to obtain their median ranks
(rmed). The regression model (2) is applied to the loge
median intensities and their ranks to estimate amed and
bmed using the least squares method,
The ranking of genes by their median intensities effec-
tively groups genes of similar overall expression level
along the log rank axis. Under the assumptions that most
genes are not differentially expressed, the reference curve
generated from the median intensities should have an
identical regression coefficient and constant to that of
each individual microarray plotted using the ranks deter-
ln lny a b rmed med med med( ) = + ( ) ( )3
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mined by the medians. For the genes which are differen-
tially expressed, the median value represents a 'center'
around which expression levels on each individual array
may vary, and the neighbouring (by rank) genes, which
do not (or only slightly) vary, act to stabilize the regres-
sion line and allow normalization to be performed.
In the second step of the normalization procedure, the
regression model was applied individually to each micro-
array using the same ranking as the reference curve,
This results in a set of coefficients ak and bk which are esti-
mated individually for each array using the least squares
method, where k is equal to the number of microarrays in
one channel systems, and equal to 2 time the number of
microarrays (one for each channel) in two channel
systems. Data from two channel arrays were treated in the
same way as one channel systems, i.e. each channel was
treated independently.
In the third step, the difference between the expected gene
intensity value on the kth array and that of the reference
curve was applied as the normalization factor,
A scaling factor was applied to the raw data before nor-
malization such that the values yk,  and  were
always greater than one to avoid negative values after log
transformation. After normalization, the same scaling fac-
tor was applied to the data to back transform to their orig-
inal magnitude. For example, if the smallest raw value in
the data set was 0.1, the unlogged raw data was multiplied
by a scaling factor of 10 before normalization, and the
unlogged normalized data was divided by the same scal-
ing after normalization.
In the special case of our third microarray data set (see
Methods: Data Acquisition) which was a boutique array,
the same procedure as described above was applied with
the following modifications. Each microarray contained
32 spots each of internal positive controls (GAPDH, glyc-
eraldehyde-3-phosphate_dehydrogenase) and internal
negative controls (spotting buffer). The medians of all
gene intensities were computed (including internal posi-
tive and negative controls), and median ranks were
assigned as described. However, only the medians of the
64 internal control spots were used to estimate amed and
bmed, and only the 64 internal control spots from each
array were used to estimate ak and bk. In both cases, the
ranks generated from the entire data set, were used. The
normalization factor was then applied over the entire data
set as described above.
An alternative to the used of internal control spots for the
normalization of boutique microarrays was also explored.
Wilson, et. al. [4] described a method wherein a set of
'housekeeping' genes is selected a priori from the data set
by virtue of their low variance in intensity and such that
the entire range of intensities observed on the microarrays
is uniformly represented. We also applied the Zipf's law
normalization technique to our boutique microarrays
using the set of housekeeping genes selected using the
method of Wilson, et. al.
In addition to the normalization method based on Zipf's
law, all data sets were normalized to a global mean (the
mean of logged intensities from all microarrays) and the
quantile method. The quantile method is applied by rank-
ing the genes in each array by intensity, taking the median
intensity at each rank, and replacing each gene intensity
with the median intensity corresponding to the same
rank. All normalization methods were compared to each
other and to the raw data distribution using box plots and
MA plots (pairwise array comparisons of the log-intensity
ratio (M) to the mean log-intensity (A)). The two channel
boutique microarray data set allowed further normaliza-
tion methods not possible on one channel array systems
to be applied. We normalized this data set using the pop-
ular loess method [19], and a modified Loess method spe-
cifically designed for boutique arrays using selected
housekeeping genes described by Wilson, et. al. [4].
Software
The Zipf's normalization procedure was initially imple-
mented as an SQL stored procedure in a relational data-
base. However, because this is not easily transferable to
other systems, we provide two further implementations, a
Perl script and an Excel macro [see Additional files 4, 5].
Implementations are available for download from our
website [29] and as additional files accompanying this
paper. Both the Perl script and Excel macro implement
matrix algebra style computation, using either built-in
functions or the Perl PDL module [30]. Normalization of
two channel arrays with the loess method was performed
using the marray package from R's Bioconductor [4].
Loess normalization using selected housekeeping genes
and the selection of the housekeeping genes themselves
was done with the tRMA package [19] which is publicly
available for download on the internet. Sample data sets
are also provided with this paper [see Additional files 6, 7,
8].
Normalization method comparison
To compare and evaluate the effectiveness of the various
normalization methods applied in this paper, several well
established methods were used along with some less com-
mon techniques. MA plots [19] are a convenient way to
examine differences in fluorescent marker efficiency and
ln lny a b rk k k med( ) = + ( ) ( )4
y y y yk k med k′ = ( ) ( ) ( )( )( ( )exp ln ln /ln 5
yˆmed yˆk
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other dye effects in two channel microarray systems. In
addition to the standard practice of generating within-
array MA plots, we apply them additionally to one chan-
nel systems and between arrays in two channel systems to
evaluate the extent to which a normalization procedure
allows for multiple pairwise comparisons between micro-
arrays. Plots of loge intensity versus loge rank fitted with
linear regressions are a way to visually evaluate the nor-
malization procedure according to the criteria of the Zipf's
Law normalization. Specifically, all arrays have identical
coefficients c and proportionality for the Zipf's power
function when the slops and y-intercepts of the regression
lines are identical. Finally, to quantify the similarity
between microarray distributions after normalization, the
mean Kolmogorov-Smirnov value was calculated over all
possible pairwise combinations of microarrays within an
experiment. In the case of two channel arrays, the mean of
within-array Kolmogorov-Smirnov values was also com-
puted (n = the number of arrays). It should be empha-
sized that even though the Kolmogorov-Smirnov values
are technically a test statistic, no statistical test is per-
formed. The values are here used only as a measure of sim-
ilarity between microarray distributions.
Microarray platform comparison
The underlying premise of the Zipf's normalization
method is that microarray data distributions follow a
power law distribution such that the relationship between
the log intensities and the log ranks is clearly linear. While
this assumption holds true for the three data sets we
present in this paper, to evaluate the general applicability
of the method we also examined eight publicly available
data sets (Table 1, data sets C-G, I, K-L) from the NCBI
Gene Expression Omnibus [18], and one unpublished
data set from an independently maintained website [31]
(Table 1, data set J). The survey contains a variety of
microarray system types (cDNA vs. Oligo based, radioac-
tivity vs. dye labeled systems, academic vs. commercially
produced) and two SAGE experiments for comparison.
Two plots were generated for each data set to ascertain the
conformity to the Zipf's power law distribution and the
log normal distribution respectively. For each data set, a
representative array was constructed by ranking the inten-
sities within each array, and then mean over ranks were
taken. To determine how well data sets follow the Zipf's
power law distribution, log intensity vs. log rank plots
were constructed and linear regressions were performed.
Data distributions, which were very linear in form, closely
follow the power law distribution. A second plot of the
distribution of (log y – µ) / σ, where y is the mean inten-
sity over ranks, and µ and σ2 are the mean and variance,
was made for each data set to visualize the conformity to
log normal distribution.
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Clontech microarray log plots Five rat Clontech microarrays from the 
panel of thirty-nine microarrays probed with rat-brain tissue. Upper left to 
lower right: a. Loge median gene intensity vs. loge rank – conformity to 
Zipf's law is demonstrated by the linear regression line (in red) b. Five 
microarrays chosen to maximize pre-normalization variability, each plot-
ted according to the gene ranks determined by their median gene intensity 
levels. c. The same five microarrays, normalized to a global median, with 
regression lines. d. The same five microarrays, normalized with the quan-
tile method, with regression lines. e. The same five microarrays normal-
ized taking Zipf's law into account, with regression lines. For plots b-d, a 
sub-sample of 50% of the data points are plotted for readability.
Click here for file
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Mean of squared log ratios from MA plots in Figure 2 In Figure 2, it is 
difficult to see that the distribution of the Zipf's normalized data is more 
closely centered around zero on the log ratio axis than the Globally nor-
malized data. To quantify this, the mean of squared log ratios was com-
puted for each MA plot. The positions of the values in this table correspond 
exactly to the positions of the plots in Figure 2. In 6 out of 8 cases, the 
mean of squared log ratio is smaller in the Zipf's normalized data than in 
the corresponding Globally normalized data.
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Additional File 3
Boutique microarray log plots Four mouse apoptosis boutique microar-
rays used in the mouse cell line experiments. This is the same data set as 
shown in Figure 4, with the array containing one channel with low expres-
sion intensities and high variability removed. Upper left to lower right: 
Loge median gene intensity vs. loge rank – a. Normalized according to 
Zipf's law, using internal positive and negative controls as proxies for the 
whole data set. b. Normalized with a loess curve fit using a selected set of 
housekeeping genes as proxies (see Methods). c. Normalized according to 
Zipf's law, using the same selected set of housekeeping genes as in b. as 
proxies d. The raw data. e. For comparison purposes only, normalized 
using the quantile method. f. For comparison purposes only, normalized 
using the standard loess method.
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Additional File 4
Requires: Microsoft Excel (Does not handle missing data values.)
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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Additional File 5
Requires: Perl (which runs on many platforms), the PDL perl module 
(Handles missing data values if PDL is compiled correctly.)
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
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Additional File 6
Microarray type: Filter based cDNA from the RZPD Number of genes: 
33,792 Number of microarrays: 31 Probed with: Total RNA from human 
sigmoidal colon. Within microarray normalization: None
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-6-37-S6.txt]
Additional File 7
Microarray type: Clonetech Atlas Rat cDNA 7738-1 Number of genes: 
558 Number of microarrays: 33 Probed with: Total RND from rat cere-
bellum and olive. Within microarray normalization: None
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-6-37-S7.txt]
Additional File 8
Microarray type: custom made glass slide Number of genes: 1024 Number 
of microarrays: 5 Probed with: Total RND from mouse cell lines. Within 
microarray normalization: None
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2105-6-37-S8.dat]
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Summary
Understanding the genetic structure of the European popu-
lation is important, not only from a historical perspective,
but also for the appropriate design and interpretation of ge-
netic epidemiological studies. Previous population genetic
analyses with autosomal markers in Europe either had
a wide geographic but narrow genomic coverage [1, 2], or
vice versa [3–6]. We therefore investigated Affymetrix Gene-
Chip 500K genotype data from 2,514 individuals belonging
to 23 different subpopulations, widely spread over Europe.
Although we found only a low level of genetic differentiation
between subpopulations, the existing differences were char-
acterized by a strong continent-wide correlation between
geographic and genetic distance. Furthermore, mean het-
erozygosity was larger, and mean linkage disequilibrium
smaller, in southern as compared to northern Europe. Both
parameters clearly showed a clinal distribution that provided
evidence for a spatial continuity of genetic diversity in Eu-
rope. Our comprehensive genetic data are thus compatible
with expectations based upon European population history,
including the hypotheses of a south-north expansion and/or
a larger effective population size in southern than in north-
ern Europe. By including the widely used CEPH from Utah
(CEU) samples into our analysis, we could show that these
individuals represent northern and western Europeans
reasonably well, thereby confirming their assumed regional
ancestry.
Results and Discussion
According to current theory, the autosomal gene pool of extant
human populations in Europe lacks sharp discontinuities [1, 2],
with the exception of known isolates such as the Finns [6, 7].
For classical genetic markers including, for example, erythro-
cyte antigens, changes in population genetic structure have
been observed to follow a predominantly southeast-northwest
gradient [1, 2], thereby apparently matching the Pleistocene
settlement of Europe, the Neolithic expansion from the Fertile
Crescent, and (at least in part) the postglacial resettlement of
Europe during the Mesolithic. Such gradient was also observed
with particular haplogroups derived from the nonrecombining
part of the Y chromosome (NRY), but other NRY data revealed
additional population structure in Europe that has been associ-
ated with various demographic events in prehistoric, historic,
and modern times [8–10]. In contrast, the European mitochon-
drial DNA pool has been found to be rather homogeneous [11].
Here, we investigated the genetic structure of the European
population by using 309,790 single-nucleotide polymorphisms
(SNPs) in 2,457 individuals, ascertained at 23 sampling sites
(henceforth referred to as ‘‘subpopulations’’) in 20 different Eu-
ropean countries. The data emerged from the genotyping of
2,514 European samples with the GeneChip Human Mapping
500K Array, followed by stringent quality control (see Table 1
and Experimental Procedures for details) and represent the
largest Europe-wide genetic study to date.
First, we quantified the amount of information that each SNP
could potentially provide about an individual’s subpopulation
affiliation by using the ancestry informativeness index In (Fig-
ure S1 available online) [12]. The maximum In value (0.09) was
observed for rs6730157 in the RAB3GAP1 gene located about
68 kb away from the Lactase (LCT) gene. Furthermore, nine of
the 20 (45%) most ancestry-informative SNPs, and 17 of the
top 100 (Table S1), were from the LCT region and previously
showed signatures of a selective sweep in CEU (Centre d’Etude
du Polymorphism Humain from Utah) samples [13]. The aver-
age In across markers was 0.0064 (standard deviation:
0.0032), which represents only 0.93% of the maximum possible
In of 0.69 in our study. (Note that this maximum would be at-
tained if a SNP was fixed for one allele in 12 subpopulations
and for the other allele in the remaining 11 subpopulations).
Second, we performed a principal-component analysis
(PCA) in which the first two PCs were found to account
for 31.6% and 17.3%, respectively, of the total variation, an
amount similar to that reported in previous studies [1, 5]. In
our study, the first two PCs revealed a SNP-based grouping
of European subpopulations that was strongly reminiscent of
the geographic map of Europe (Figure 1; Figure S2). The first
PC aligned subpopulations according to latitude, with the
two Italian subpopulations at one end and the Finnish subpop-
ulation at the other. The second PC tended to separate sub-
populations more according to longitude, with the Finnish
subpopulation showing the largest values and the Irish and
UK subpopulations showing the lowest values. The apparent
geographic footing of the two PCs received additional support
from an observed statistically significant positive correlation
(Pearson r2 = 0.632, two-tailed p < 10215) between the genetic
distance (Euclidian distance between the median first two
eigenvectors of the PCA) and the geographic (great-circle)
distance between the analyzed subpopulations.
Third, we searched for genetic barriers [14] in our dataset by
using the same genetic and geographic distance matrices.
This analysis identified two statistically significant barriers
for the 23 subpopulations. One barrier was observed between
the Finnish and all other subpopulations (first PC considering
FI against the rest: r2 = 0.074, two-tailed p < 10215; second
PC considering FI against the rest: r2 = 0.33, two-tailed p <
10215) and the other one between the two Italian and all other
subpopulations (first PC considering IT1 and IT2 against the
Table 1. European Subpopulation Summary Statistics
Subpopulation Code
Total No.
Samples
Final No.
Samples*
Sex Ratio
(M:F)
Norway (Førde) NO 52 52 1.74
Sweden (Uppsala) SE 50 46 all male
Finland (Helsinki) FI 47 47 0.74
Ireland IE 37 35 4.29
UK (London) UK 197 194 8.85
Denmark (Copenhagen) DK 60 59 1.22
Netherlands (Rotterdam) NL 292 280 all female
Germany I (Kiel) DE1 500 494 1.08
Germany II (Augsburg) DE2 500 489 1.02
Austria (Tyrol) AT 50 50 all male
Switzerland (Lausanne) CH 134 133 0.81
France (Lyon) FR 50 50 2.13
Portugal PT 16 16 0.78
Spain I ES1 83 81 1.02
Spain II (Barcelona) ES2 48 47 0.71
Italy I IT1 107 106 1.38
Italy II (Marches) IT2 50 49 all male
Former Yugoslavia YU 58 55 1.90
Northern Greece EL 51 51 1.43
Hungary HU 17 17 0.54
Romania RO 12 12 1.00
Poland (Warsaw) PO 50 49 all male
Czech Republic (Prague) CZ 53 45 0.96
Total 2,514 2,457
Total number of samples, final number of samples after data cleaning, and
the sex ratio (male:female) of the final sample data set for each subpopula-
tion. * is after stringent quality control.
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rest: r2 = 0.37, two-tailed p < 10215; second PC considering IT1
and IT2 against the rest: r2 = 0.014, two-tailed p = 2.313 1029).
Fourth, we studied the geographic distribution of genetic di-
versity by computing mean heterozygosity and mean linkage
disequilibrium (LD) based upon HR2 [15] between markers
at a distance < 10 kb for each subpopulation. Results from
both analyses showed that the genetic diversity tended to be
larger, and the LD smaller, in southern Europe as compared
to northern Europe (Figure 2). Moreover, both analyses
supported a genetic gradient of south-north orientation (r2
adjusted for the number of data points between the mean ob-
served heterozygosity and latitude: 0.76, p = 3.80 3 1028; ad-
justed r2 between HR2 and latitude: 0.71, two-tailed p = 4.333
1027) but not of west-east orientation (adjusted r2 between
heterozygosity and longitude: 0.03, two-tailed p = 0.416;
adjusted r2 between HR2 and longitude: 0.099, two-tailed p =
0.078). Spatial autocorrelation analysis of both variables re-
vealed statistically significant (p < 0.05) patterns compatible
with a clinal distribution as indicated by the presence of posi-
tive and statistically significant autocorrelation values for small
pair-wise distances and negative and statistically significant
Moran’s I values for large distances (see Figure 2). Bearing
analysis [16] revealed for the heterozygosity measure the
maximal angular correlations (r = 0.69) at 87 and the minimal
(r = 20.153) at 165, as well as for HR2 the maximal at 55
(r = 0.67) and the minimal (r = 20.167) at 160, thus also
suggesting a south-to-north spatial distribution of both vari-
able. These results are compatible with larger effective popu-
lation sizes in the south than in the north of Europe and/or a
population expansion from southern toward northern Europe.
Hierarchical analysis of molecular variance (AMOVA) [17]
revealed that clustering the individuals according to four geo-
graphic groups—north (NO, SE, FI), north-west/central (IE, UK,
DK, NL, DE1, DE2, AT, CH, FR), east (HU, RO, PO, CZ), and
south (PT, ES1, ES2, IT1, IT2, YU, EL)—explained an average
of 0.17% (95% coefficient interval: 0.0% to 0.91%) of the total
genetic variance, whereas individual subpopulation affiliation
explained 0.25% (95% coefficient interval: 0.0% to 1.25%).
Overall, our study showed that the autosomal gene pool in
Europe is comparatively homogeneous but at the same time
revealed that the small genetic differentiation that is present
between subpopulations is characterized by a significant
correlation between genetic and geographic distance. Further-
more, the qualitative nature of these results is in close agree-
ment with expectations based on human migration history in
Europe. The major prehistoric waves of human migration in
Europe followed south and southeastern to north and north-
western directions [1], including the first Paleolithic settlement
of the continent by anatomically modern humans [18], most of
the postglacial resettlement during the Mesolithic [19], and the
farming-related population expansion during the Neolithic [18,
20]. Thus, both the level and the change in neutral autosomal
Figure 1. SNP-Based PCA of 2,457 European Individuals from 23 Subpopulations
(A) Kernel density plot of the first two dimensions of a SNP-based PCA using those 309,790 SNPs from the GeneChip Human Mapping 500K Array Set
(Affymetrix) that passed quality control.
(B) Geographic distribution of the 23 subpopulations; capitals were used as the respective landmark if location information was either unspecific or lacking
(see Table 1 for further sample details).
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variation in Europe can be expected to roughly follow southern-
to-northern gradients as we observed, with the possible ex-
ception of population isolates as observed for the Finns. On
the other hand, migration events in more recent (i.e., historic)
times are presumed to have had a more homogenizing effect
upon the previously established genetic landscape, as a result
of their sporadic nature and haphazard geographic orientation
[2]. This implies that genetic differences between extant Euro-
pean subpopulations can be expected to be small indeed.
The genetic landscape described by thew300,000 autosomal
SNPs analyzed here closely resembles that previously ob-
tained with 128 alleles from 49 classical markers (see Table
1.3.1 in [1]). This similarity is highlighted by a significant corre-
lation (r = 0.516; two-tailed Mantel test p = 0.0042, performed
with 10,000 Monte Carlo permutations) between the pair-wise
FST values [21] computed for the 19 European subpopulations
that overlapped between the two datasets (Danish, Dutch,
Yugoslavian, Hungarian, Irish, Italian, Portuguese, Spanish,
Swiss, English, German, Austrian, Finnish, French, Greek, Nor-
wegian, Polish, Swedish, and Czechoslovakian). This notwith-
standing, a stronger correlation between FST and great-circle
geographic distances was observed for the subpopulations
when the SNPs from our study were used (r = 0.661; two-tailed
Mantel test p = 0.00010, performed with 10,000 Monte Carlo
permutations) as compared to the classical markers (r =
0.503, two-tailed Mantel test p = 0.00020, performed with
10,000 Monte Carlo permutations).
Previous studies based on genome-wide SNP diversity
reported differences between individuals of southern and
northern/central European ancestry [3, 5, 6] and, to a lesser ex-
tent, between those of eastern and western European ancestry
[3], which were not confirmed in our study. They mostly relied
on the analysis of European Americans whose geographic as-
signment was determined from self-reported family records.
Although genetic studies using European Americans can re-
veal important information about the genetic structure of the
European ancestry of European Americans, caution must be
exercised when drawing conclusions about the current ge-
netic structure of Europe from European Americans because
(1) European migrants may not have been representative of
their country of origin, (2) the temporal difference introduced
by sampling second- or third-generation descendants means
Figure 2. Geographic Distribution of Two Measures of Genetic Diversity across the European Population
(A and B) Isoline map (A) of Europe based on the mean observed heterozygosity in each of 23 European subpopulations with (B) corresponding spatial
autocorrelogram.
(C and D) Isoline map (C) of Europe based on the mean observed linkage disequilibrium based on HR2 in each of 23 European subpopulations with (D)
corresponding spatial autocorrelogram. Both spatial autocorrelograms showed statistically significant departures from randomness (p < 0.05). For each
distance class, the number of subpopulation pairs included and the statistical significance (*, p < 0.05; **, p < 0.01; ***, p < 0.001) are provided.
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that allele-frequency estimates inevitably ignored recent
population movements (i.e., WWII-related migrations), and (3)
self-reported geographic origin is error prone [22]. Our study
avoided these potential pitfalls by using large samples of indi-
viduals of genuinely European origin, as evidenced by the doc-
umentation of their respective place of birth or residence being
in one of the named subpopulations, and with comprehensive
continent-wide coverage.
It is of general interest to place the CEU samples, widely
used in genetic epidemiological and population genetic stud-
ies as representing the European population, into the context
of our findings. The CEPH-CEU panel comprises U.S. Ameri-
cans who were collected in Utah in 1980 and who are assumed
to have descended from migrants originating from northern
and western parts of Europe [23]. The samples were also
included in the International HapMap Project and formed the
basis of selecting tagging SNPs used in current genome-
wide association studies with Illumina SNP arrays. Whereas
a previous study [3] confirmed the grouping of the CEPH-
CEU samples with other northern and western European sub-
populations, our study was capable of providing their most
precise positioning on the European genetic map (Figure 3).
It turned out that, while the CEPH-CEU panel was indeed
largely representative of northwestern and central Europeans,
parts of Scandinavia as well as southern and eastern Europe
were not well represented by these samples (Figure 3).
Estimated inflated false-positive rates for all subpopulations
were largest in the Finns, followed by the two Italian subpopu-
lations (see Table S2). This implies that researchers conduct-
ing genetic-association studies in at least these regions, using
the CEPH-CEU samples as controls, may be at increased risk
of false-positive associations. Our confirmation of the regional
European origin of the CEPH-CEU samples also indicates that
inferring the geographic origin of an unknown person from au-
tosomal DNA markers, which is highly relevant in the forensic
Figure 3. Position of CEPH-CEU Samples in a SNP-
Based PCA Kernel-Density Plot of 23 European
Subpopulations
CEU individuals (U.S. Americans of European
descent from Utah) are plotted as open circles. For
details, see Figure 1 and Table 1.
context, might now be feasible down to
the level of European subregions, at least
when a large number of genetic markers
and a reference database, such as are
applied here, are used.
Conclusions
Our comprehensive SNP genotype data
from 23 European subpopulations, provid-
ing a dense coverage at both the geo-
graphic and genomic level and represent-
ing the largest Europe-wide genetic study
to date, allowed us to describe the genetic
structure of the European population with
the highest resolution. Although the amount
of differentiation within the European auto-
somal gene pool was found to be small, the
existing genetic differences nevertheless
correlated well with geographic distances.
Furthermore, mean heterozygosity was
larger, and mean linkage disequilibrium smaller, in southern
than in northern European subpopulations, and both parame-
ters exhibited a continuous clinal distribution across Europe.
Overall, our results were compatible with expectations based
on European population history, mainly the prehistoric popula-
tion expansion from southern to northern Europe and/or a
larger effective population size in the south as compared to
the north of Europe. Our dataset also allowed placement of
the widely used CEPH-CEU samples onto the European ge-
netic landscape, essentially confirming their genetic ancestry
in northern and western Europe.
Experimental Procedures
Samples and Genotyping
The GeneChip Human Mapping 500K Array Set (Affymetrix) was used to ge-
notype 500,568 SNPs in 2,514 individuals from 23 different sampling sites
(henceforth termed ‘‘subpopulations’’) located in one of 20 different Euro-
pean countries. Genotyping according to the instructions provided by
the manufacturer was carried out at one of seven specialized centers: the
Cologne Center for Genomics at the University of Cologne (Germany) for
DE1, NO, SE, FI, AT, FR, ES2, IT2, EL, PO, and CZ; the Helmholtz Zentrum
Mu¨nchen - German Research Center for Environmental Health for DE2;
the genetics laboratory of the Department of Internal Medicine, Erasmus
MC (Netherlands) for NL; and the RH Microarray Centre Rigshospitalet, Co-
penhagen University Hospital (Denmark) for DK (see Table 1 for abbreviation
explanations). Samples from the GlaxoSmithKline-sponsored POPRES pro-
ject (IE, UK, CH, PT, ES1, IT1, YU, HU, and RO) were genotyped at Expres-
sion Analysis (Durham, NC, USA) and at Gene Logic (Gaithersburg, MD,
USA) (see Table 1 for abbreviation explanations). Some samples belonged
to existing control population studies, with detailed descriptions available
elsewhere: KORA [24] for DE2, PopGen [25] for DE1, the Rotterdam Study
[26–28] for NL, and POPRES (drawn from the LOLIPOP and CoLaus studies)
for IE, UK, CH, PT, ES1, IT1, YU, HU, and RO [29–31]. Samples were drawn
randomly from these pools or, in the case of POPRES, were ascertained on
the basis of sample-size requirements. European migrants from non-Euro-
pean regions were not included in the initial analysis. For 11 of the subpop-
ulations (NO, SE, FI, AT, FR, ES2, IT2, EL, PO, CZ, and DK), samples were
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obtained from healthy unrelated volunteers: Norwegian samples (NO) from
blood donors of the Førde region, Swedish samples (SE) from the Uppsala
region [32], Finnish samples (FI) from the Helsinki area with parents and
grandparents originating from various regions in Finland, Austrian samples
(AT) from the Tyrol region with parents originating from Tyrol, French sam-
ples (FR) from blood donors of Lyon with parents originating from the Rhoˆne
Alpes area, Spanish samples (ES2) from Catalonia of blood donors from
rural areas who speak Catalan as their mother tongue and who had regional
Catalan ancestry for at least two generations [33], Italian samples (IT2) from
blood donors of the upland of the Marches region [34], Greek samples (EL)
from the north of the country [35], Polish samples (PO) from the Warsaw re-
gion of central Poland [36], Czech samples (CZ) from the central Bohemian
region in and around Prague, and Danish samples (DK) from the Danish
Blood Donor Corps in the Copenhagen area. In addition, GeneChip Human
Mapping 500K Array data from CEPH-CEU samples were retrieved from the
Affymetrix website (http://www.affymetrix.com).
Quality Assessment and Control Procedure
Array-based SNP genotypes were subjected to stringent quality control:
First, each individual was required to have a genotype call rate R 93%,
with the dynamic model (DM) algorithm with a confidence score of 0.26,
and a per-individual call rate R 95% for all individuals genotyped by the
same facility, with the Bayesian robust linear model with Mahalanobis dis-
tance classifier (BRLMM) algorithm with a confidence score of 0.5. The
call rate was defined here as the proportion of unambiguous genotypes
among either all SNPs (per-individual call rate) or all individuals (per-marker
call rate), respectively. Markers that were monomorphic (1.4% of the total),
that were located on the X chromosome (2.1%), or that had a per-marker call
rate% 90% in at least one genotyping facility (5.7%) were excluded, as were
those showing a significant (p% 0.05) deviation from Hardy-Weinberg equi-
librium (HWE) in at least one subpopulation (31.3%). HWE was tested by
means of a c2 test, or by Fisher’s exact test when the observed or expected
number of a given genotype was less than 5. This method was preferred
over others that have been shown to be more powerful [37] because the
computational requirements of these methods increase exponentially with
sample size and were thus too resource intensive for our study. The average
proportion of heterozygous genotypes at X chromosomal markers was
estimated per individual in order to detect false gender assignments. Male
subjects can be expected to show X chromosomal heterozygosity propor-
tions% 1%, reflecting the overall genotyping error rate, and female subjects
should show proportions near the average heterozygosity (26%) of the
analyzed X chromosomal SNPs. Average identity-by-state (IBS) distances
were calculated for a given set of markers as the average genetic dissimilar-
ity between pairs of individuals. Analysis of IBS values within subpopula-
tions allowed us to detect two types of outliers: (1) cognate relatives, i.e.,
individuals that were genetically more similar than expected to another
member of the same subpopulation, and (2) ‘‘aliens,’’ i.e., individuals that
were far less genetically similar than expected to the rest of the subpopula-
tion. Formally, cognate relatives were defined as pairs of individuals having
a pair-wise IBS value larger than the so-called ‘‘Tukey outlier criterion’’ when
compared with the rest of pairs of individuals of the same subpopulation,
i.e., the median IBS plus three times the interquartile range (IQR) in that sub-
population. In this case, the partner with the lower call rate was excluded.
Aliens were defined as individuals with at least 60% of their pair-wise IBS
values below the median minus three times the IQR. These two criteria led
to the exclusion of 56 individuals from further analysis (Table 1). One individ-
ual identified as female had an average proportion of heterozygous X chro-
mosomal markers of only 0.6% and was thus excluded from further analysis.
In total, quality control left 2,457 individuals (97.6%) and 309,790 markers
(62.4%) for inclusion in subsequent analysis. AMOVA [17] was performed
to ascertain the magnitude of variation attributable to the respective geno-
typing center or subpopulation. The mean amount of genetic variance
explained among genotyping centers was 0.095% (95% confidence interval:
0% to 0.71%), whereas subpopulation affiliation explained 0.63% of the
variance (95% confidence interval: 0% to 2.86%). As expected, the largest
amount of genetic variation was explained by differences between individ-
uals (99.72%; 95% confidence interval: 98.61% to 100.00%). Data are
available on request from the authors according to the regulations of the
participating studies and sample cohorts.
Statistical Data Analyses
The ancestry-informativeness index In was estimated for each marker as
described eslewhere [12]. Principal-component analysis was performed
with the Eigensoft program with the default settings [38]. Population-wise
kernel densities were computed from the first two PCs with the adehabitat
R package [39] and subjected to least-squares crossvalidation [40] that
used 80% of individuals per subpopulation for training. Pearson correlation
coefficients were computed for the genetic distance between the subpop-
ulations (represented by the respective median over all individuals in that
subpopulation of the first two eigenvectors) and the great-circle geographic
distance. The statistical significance of these correlation coefficients was
assessed by means of a Mantel test [41]. Barrier analysis was performed
on the basis of the Monmonier’s algorithm [14]. Locus-wise AMOVA [17]
was conducted after clustering the European subpopulations by genotyp-
ing center as well as by the use of four geographic groups. Negative per-
centages of explained variation were settled to 0. Both mean heterozygosity
and mean linkage disequilibrium computed by means of HR2 [15] were com-
puted with a subsample of ten individuals per population in order to adjust
for possible influence of sample size [42]. Spatial autocorrelation and Bear-
ing analyses were performed with the software PASSAGE 1.1 [43]. Isoline
maps were performed with the Golden Surfer 8 software [44], with the in-
verse-distance method used for interpolation points. Isoline levels were
defined to include the value of at least one of the 23 populations with inter-
vals of 0.001 in the case of heterozygosity and 0.002 in the case of HR2. For
evaluation of the extent to which the CEPH-CEU samples are representative
of the subpopulations used in the present study, marker-wise tests of asso-
ciation (Fisher’s exact test) were performed each time with the CEPH-CEU
samples as ‘‘controls’’ and a given subpopulation as ‘‘cases.’’ The false-
positive rate was defined as the percentage of markers yielding a p value
< 0.05. If the CEPH-CEU samples were representative of a subpopulation,
the false-positive rate would be around 0.05, whereas higher false-positive
rates indicate that the CEPH-CEU samples may not be representative of the
respective subpopulation.
Supplemental Data
Supplemental Data include two tables and two figures and can be found
with this article online at http://www.current-biology.com/cgi/content/full/
18/16/1241/DC1/.
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Genetic matching potentially provides a means to alleviate the effects of incomplete Mendelian
randomization in population-based gene–disease association studies. We therefore evaluated the genetic-
matched pair study design on the basis of genome-wide SNP data (309 790 markers; Affymetrix GeneChip
Human Mapping 500K Array) from 2457 individuals, sampled at 23 different recruitment sites across
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Europe. Using pair-wise identity-by-state (IBS) as a matching criterion, we tried to derive a subset of
markers that would allow identification of the best overall matching (BOM) partner for a given individual,
based on the IBS status for the subset alone. However, our results suggest that, by following this approach,
the prediction accuracy is only notably improved by the first 20 markers selected, and increases
proportionally to the marker number thereafter. Furthermore, in a considerable proportion of cases
(76.0%), the BOM of a given individual, based on the complete marker set, came from a different
recruitment site than the individual itself. A second marker set, specifically selected for ancestry sensitivity
using singular value decomposition, performed even more poorly and was no more capable of predicting
the BOM than randomly chosen subsets. This leads us to conclude that, at least in Europe, the utility of the
genetic-matched pair study design depends critically on the availability of comprehensive genotype
information for both cases and controls.
European Journal of Human Genetics advance online publication, 21 January 2009; doi:10.1038/ejhg.2008.266
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Introduction
In both classical epidemiology and clinical research,
potential confounders are usually controlled for by one
of two different means, matching or randomization. In
genetic studies, however, including the large number of
genome-wide association (GWA) studies that have recently
been published,1 – 3 only so-called ‘Mendelian’ randomiza-
tion has been employed to control for genetic confoun-
ders, whereas matching by genotype has not played an
important role.4 Nevertheless, there has always been some
awareness among genetic epidemiologists that Mendelian
randomization may fail, thereby leading to false positive
reports of disease genes or to biased effect size estimates.5
One possible cause of such failure may be systematic
differences in terms of the rate at which individuals with a
particular phenotype or genotype are sampled from
genetically distinct populations. Therefore, two statistical
methods to retrospectively rectify genetic imbalances in
case-control studies were developed in the late 1990s, both
of which rely upon genotyping loci that are unrelated to
the genetic variants under study (ie unlinked and not in
linkage disequilibrium). The ‘genomic control’ approach6
uses marker genotypes to correct the employed test
statistic, whereas ‘structured association’7 infers the num-
ber of populations represented in a sample, and then
assigns each individual to one of these populations with a
certain probability.
With the possibility to effectively genotype large num-
bers of single nucleotide polymorphisms (SNPs) in large
numbers of individuals, using microarray technology,8 the
effects of imperfect Mendelian randomization can, in
principle, also be alleviated by genetic matching. If
individuals from different samples such as cases and
controls were as closely matched as possible in terms of
their identity-by-state (IBS) status at a large number of
SNPs, it may be surmised that most systematic population
genetic differences would be eliminated between the
ensuing sub samples. However, genetic matching would
have to be based on markers from outside the genomic
region under study to avoid over-matching. This implies
that, in practise, repeated matching may be necessary if
multiple or even GWA assessments are due. In any case,
genetic matching could of course be accomplished effi-
ciently with the use of genome-wide microarray data, but
such a costly strategy may not be necessary if a set of ‘best
genetic match’ (BGM) markers could be established in
advance that are capable of capturing the major population
genetic characteristics of relevant extant populations.
Once a set of BGM markers has been found, it can be used
in two ways: either to retrospectively confirm whether two
samples of interest were genetically well-matched or to
select members of matched samples prospectively, before
any additional genotyping.
Recruitment of phenotypically well-characterized
control samples is one of the major bottlenecks of genetic
epidemiological and pharmacogenetic research. The use of
common controls across different association studies has
proven to be an efficient solution to this problem,
pioneered at a local level by the Wellcome Trust Case
Control Consortium (WTCCC),3 and since adopted, for
example, by the US-American Genetic Association Information
Network (GAIN)1 and the German National Genome
Research Network (‘Nationales Genomforschungsnetz’,
NGFN).9 However, the number and geographical distribution
of control samples required for the common controls approach
to be feasible at a broader geographical level are currently
unknown.
In the present study, we investigated three issues related
to the genetic-matched pair study design, using genome-
wide SNP data from across Europe: (1) the prospects of
identifying a small subset of SNPs that accurately predict
the ‘best’ genome-wide matching partner of a given
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individual, (2) the distribution of ‘best’ genetic-matching
partners between the European subpopulations and (3) the
inter-individual variability in terms of the uniqueness of
the ‘best’ genetic-matching partner. To this end, we
analyzed the genotypes of 309 790 markers obtained from
the GeneChip Human Mapping 500K Array Set in 2457
individuals, ascertained at one of 23 recruitment sites. The
European population is important in this context, not only
because of the historical interest in these people and their
descendants in the Americas, Australia and elsewhere, but
also because they are a major focus of both genetic
epidemiological and pharmacogenetic research.1,3
Material and methods
Samples, genotyping and quality control
The GeneChip Human Mapping 500K Array (Affymetrix)
was used to genotype 500 568 SNPs in 2514 individuals
from 23 different sampling sites (henceforth, termed
‘subpopulations’), distributed over 20 different European
countries. Subpopulation sizes ranged from 12 to 500
individuals (Table 1). Sex ratios differed markedly between
subpopulations, with some comprising only females or
males, respectively. Genotyping was carried out at six
different facilities. For further details, see Lao et al.10
Array-based SNP genotypes were subjected to stringent
quality control as described earlier.10 Briefly, markers,
which had a genotype call rateZ93%, were monomorphic,
located on the X chromosome or had a per marker call rate
r90% in at least one genotyping facility were excluded, as
were those showing a significant (Po0.05) deviation from
Hardy–Weinberg equilibrium (HWE) in at least one
subpopulation. Individuals deemed genetic outliers to
their subpopulation of origin, based on low average IBS
to the remaining individuals, were omitted from the
respective subpopulation. In total, quality control left
2457 individuals (97.6%) and 309 790 markers (62.4%)
for inclusion in subsequent analyses. The set of quality
controlled markers will henceforth be referred to as marker
set C. Ascertainment of a marker set for genetic matching
was carried out with internal validation, using 2/3 of the
members of each subpopulation (ie, 1638 randomly chosen
individuals) as the training set, and using the remainder
(819 individuals) as the validation set (Table 1).
All data were stored as either flat files or in a customized
database with an interface to the R statistical software. All
data analysis, except for the IBS estimation, was done in R
version 2.4.111 using customized scripts. IBS calculations
and selection of marker sets were carried out using custom
Cþþ programs. All software is available from the authors
on request.
Best genetic match marker set
For the ascertainment of a marker subset M of C that would
allow us to identify ‘best’ genetic-matching partners, we
will use a set-specific criterion, D(M) that is related to the
IBS between given individuals and their matching partners,
as selected on the basis of M (see below). In this context, we
will use the term ‘best overall match’ (BOM) to denote that
individual or group of individuals who maximize
the average pair-wise IBS with the individual of interest
for the complete marker set C. Ideally, we would want to
ascertain a subset of markers that consistently lead to
the selection of matching partners with an IBS with the
reference individual that is close to the IBS between
the reference individual and its BOM.
More formally, if the genotype (g), of a given SNP is
encoded by the dose of one of its two alleles (ie, as 0, 1 or
2), then the IBS between any two individuals x and y equals
1|g(x)g(y)|/2 for that SNP. Here, g(x) and g(y) denote the
genotypes of x and y, respectively. For a marker set M, let
iM(x,y) be the average IBS, taken over all markers in M, and
let iM(x) denote the maximum iM(x,y), taken over all
individuals y other than x. Finally, if MDN are two nested
marker sets, let iM,N(x) be the average iN(x,y) taken over all y
for which iM(x,y)¼ iM(x). For a marker set MDC, D(M) is
defined as the average difference |iC(x)iM,C(x)|, taken over
all individuals x and weighted by the inverse of the size of
the subpopulation to which x belongs.
We used forward selection from marker set C to ascertain
marker sets that successively minimized the D criterion.
The ensuing marker sets will be referred to as the best
genetic match (BGM) marker sets. Upper and lower base-
lines for D were computed as follows. The upper baseline
was obtained from randomly chosen marker sets of varying
size (10–100 in steps of 10), with 1000 sets sampled for
each set size value. The lower baseline was obtained from
marker sets that theoretically should have captured most of
the genetic variation present in the individuals under
study, ie sets for which any additional marker would have
been in strong linkage disequilibrium with the markers
already included. Each chromosome was thus divided into
bins of 20 kb, based on the mean swept radius of 500 kb
estimated for the European population.12,13 The swept
radius is the distance at which the average association
between two markers, measured by r2, is reduced to
approximately one-third (more precisely, e1) of its initial
value. A bin size of 20 kb therefore ensures an average r2 of
e10/500¼0.98 between markers in the bin. Markers were
then randomly selected from bins, one at a time, and D
calculated for the resulting marker set. The described
selection process was repeated 1000 times and the mean
D value taken as the lower baseline, ie the expectation of D
at r2-based saturation.
Ancestry-sensitive marker set
To compare the BGM set, which focuses on inter-individual
genetic variation with a marker set that was ascertained
with the aim to highlight inter-population variation, we
generated an ancestry-sensitive marker (ASM) set using the
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singular value decomposition (SVD) method with redun-
dant marker reduction described by Paschou et al.14,15
Global allele frequencies were used to interpolate missing
data as suggested by the authors. Some 228 individuals
were eliminated from the training set during PCA analysis
with Eigensoft216 using the standard criterion of having an
ancestry coefficient 46 standard deviations in at least one
of the eigenvector axes. SVD was carried out with SVDLIBC
(version 1.34, http://tedlab.mit.edu/~dr/SVDLIBC), a C
library based on the SVDPACK library.17 Rank-revealing
QR matrix decomposition was carried out in Octave
version 2.0.1718 to reduce the redundancy of the first
5000 markers, ordered by the first SVD eigenvector. This
resulted in a set of the same size (ie 100 markers) as the
BGM set.
Distribution of best genetic match pairs
A count matrix was generated that contains, for each pair
of subpopulations, the number of times an individual in
the first subpopulation had their BOM in the second
population. Cell counts were tested for a deviation from
the null hypothesis that BOMs were drawn randomly from
subpopulations using a two-tailed exact test as implemen-
ted in the R routine binom.test. A plot of directed graphs
representing the relationships between individuals and
their BOMs was generated using Graphviz.19
False positive rates
Thresholds for the false positive rates of population-based
gene–disease associations in Europe were determined from
contrived case-control experiments, using PLINK version
1.0320 on all markers in set C (Fisher’s exact test on allele
frequencies). These mock studies were carried out for all
pair-wise combinations of subpopulations, each time
labeling one subpopulation as ‘cases’ and the other as
‘controls’. The percentage of markers with P-values o0.05
was reported. As the variance of the P-value is inversely
related to sample size, false positive rates were not
estimated for subpopulations with sample sizes o20 (PT,
HU and RO; see Table 1 for subpopulation abbreviations).
Results
Best genetic match and ancestry sensitive marker sets
Two subsets of markers (BGM and ASM) were ascertained
from the complete marker set using either IBS-based
forward selection or SVD with redundant marker reduc-
tion, respectively. As the decrease in D as a function of
marker set size levelled off very rapidly (see Figure 1), BGM
marker selection was terminated at 100 SNPs (Supplemen-
tary Table 1). For the sake of comparability, the ASM set was
chosen so as to contain the same number of markers as the
BGM set (Supplementary Table 2). Interestingly, the top
5000 markers of the provisional ASM set included various
SNPs annotated to genes known to stratify the European
Table 1 European subpopulation summary statistics
Subpopulation Code No. samples Final no. samples No. training
Norway (Frde) NO 52 52 (0.63) 35
Sweden (Uppsala) SE 50 46 (1.00) 31
Finland (Helsinki) FI 47 47 (0.43) 31
Ireland IE 37 35 (0.80) 23
UK (London) UK 197 194 (0.90) 129
Denmark (Copenhagen) DK 60 59 (0.56) 39
Netherlands (Rotterdam) NL 292 280 (0.00) 187
Germany I (Kiel) DE1 500 494 (0.52) 329
Germany II (Augsburg) DE2 500 489 (0.51) 326
Austria (Tyrol) AT 50 50 (1.00) 33
Switzerland (Lausanne) CH 134 133 (0.44) 89
France (Lyon) FR 50 50 (0.68) 33
Portugal PT 16 16 (0.44) 11
Spain I ES1 83 81 (0.51) 54
Spain II (Barcelona) ES2 48 47 (0.43) 31
Italy I IT1 107 106 (0.58) 71
Italy II (Marche) IT2 50 49 (1.00) 33
Former Yugoslavia YU 58 55 (0.65) 37
Northern Greece EL 51 51 (0.59) 34
Hungary HU 17 17 (0.35) 11
Romania RO 12 12 (0.50) 8
Poland (Warsaw) PO 50 49 (1.00) 33
Czech Republic (Prague) CZ 53 45 (0.51) 30
Total 2514 2457 1638
Subpopulation, site of sample origin, with more specific location details given in parentheses; No. samples, total number of samples genotyped; Final
no. samples, number of samples that passed stringent quality control, with proportion of males in parenthesis (for details, see text); No. training, size of
the training set used for marker selection.
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gene pool as a result of recent positive selection acting
differently in different geographic regions, including
HERC221 (ranked 7), OCA222 (ranked 33), LCT23 (ranked
262) and TYRP124 (ranked 1138).
A graphical representation of the forward selection
process leading to the BGM set is provided in Figure 1. In
the validation set, the D criterion decreased byB10% until
it levelled off at B20 markers, and decreased only margin-
ally thereafter. Although forward selection on the training
set showed a promising reduction in D value, the validation
D for the 100 top markers comprising the BMG set was still
at 9.3 105, which is 14.3% lower than the upper
(random) baseline but exceeds the lower baseline of
1.5105 by a factor of six. This implies that the
genome-wide similarity of two European individuals is
hard to predict with sufficient accuracy on the basis of a
small, specifically selected marker set, and that the little
benefit that can be gained in this respect already arises
from 100 markers or even fewer. By comparison, the
capacity of the ASM set for BOM prediction was found to
be indistinguishable from the upper (random) baseline, ie,
it performed no better than randomly drawn marker sets.
Distribution of best overall matches (BOMs)
A significant amount of genetic similarity between the
European subpopulations is revealed by an assessment of
the subpopulation of origin of BOMs (Table 2). In a
considerable proportion of cases (1868/2457 or 76.0%),
the BOM of a given individual belonged to a different
subpopulation than the individual itself. That this was
particularly so when individuals or BOMs came from
subpopulations with large sample sizes (DE1, DE2 and
NL) was presumably due to the wider range of genetic
diversity captured by these samples, but may also reflect
their concurrent geographic location in central Europe. On
the other hand, for some relatively isolated subpopulations
(FI and IT2) the source of the BOM was mostly the
subpopulation itself, reflecting their separation also seen
in genetic barrier analysis and, in the case of the Finns,
principle component analysis.10 Closer inspection at the
individual level revealed that some individuals were
disproportionately more often selected as BOMs than
others (Figure 2). Thus, of the 2457 individuals examined,
1860 (75.7%) were never deemed a BOM at all. This is
significantly higher than the expected number (1553.3,
63.2%) if BOMs were drawn at random (w2¼165.1, 1 df,
Po0.001). At the same time, 120 individuals were chosen
as BOMs at least five times, which is a significant excess
over expectation (9.0, 0.36%, w2¼1401.9, 1 df, Po0.001).
The subpopulation of origin of the 10 most frequently
ascertained BOMs was generally among those central
Europeans who also had the largest sample size (DE1 five,
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Figure 1 IBS-based forward selection of best genetic match (BGM) marker sets. The upper baseline for D is illustrated by box-whisker plots, each
generated from 1000 random selections of a marker set of given size. The lower baseline for D (dotted line) is provided by a marker set for which any
additional markers could be expected to be in strong linkage disequilibrium (r240.98) with at least one marker already included in that set (for details,
see text). Selection of the BGM marker sets is depicted by a solid line; the performance of ASM sets of various sizes is illustrated by a dashed line. All D
values were calculated from the validation set of individuals. The training set D values obtained for the BGM marker sets are included for reference
(dash-dotted line).
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DE2 two and NL one), with the notable exception of DK
(59 individuals, yet holding two of the top 10 positions;
Figure 2). Interestingly, barring of the 10 most frequently
chosen BOMs left the number of times the BOM was
found outside the subpopulation of origin of the individual
of interest virtually unchanged (1862/2457 or 75.8%,
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Figure 2 Distribution of the number of times an individual was deemed a BOM. The observed distribution is marked by circles. Also included is a
Poisson distribution with the same mean as the sample mean (marked by squares), which approximately corresponds to the theoretical expectation if
best overall matching (BOM) were selected at random. The codes of the subpopulation of origin of the 10 most frequently selected BOMs are given at
the upper right edge of the plot.
Table 2 Count matrix of BOM (best overall match) affiliation
NO SE FI IE UK DK NL DE1 DE2 AT CH FR PT ES1 ES2 IT1 IT2 YU EL HU RO PO CZ Total
NO 8 2 0 0 0 0 3 25 7 0 0 0 0 0 0 0 3 0 0 0 0 4 0 52
SE 6 1 0 0 2 2 4 22 5 0 2 0 0 0 0 0 2 0 0 0 0 0 0 46
FI 1 0 39 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 47
IE 1 0 0 4 12 3 3 3 3 0 0 2 0 0 0 0 4 0 0 0 0 0 0 35
UK 2 0 0 8 27 23 40 62 15 0 1 3 0 0 0 0 10 1 0 0 0 2 0 194
DK 1 0 0 0 0 10 13 23 7 0 0 0 0 0 0 0 2 0 0 0 0 3 0 59
NL 4 1 0 1 14 45 94 79 16 0 3 1 0 0 0 0 8 0 1 0 0 11 2 280
DE1 19 1 0 4 21 74 60 230 54 0 4 1 0 0 0 0 10 0 0 0 0 16 0 494
DE2 9 0 0 5 24 68 83 179 90 3 10 1 0 0 0 0 8 0 0 0 0 9 0 489
AT 0 0 0 0 3 8 7 15 13 0 0 0 0 0 0 0 3 0 0 0 0 1 0 50
CH 2 1 0 1 18 15 26 36 20 2 8 1 0 0 0 0 1 0 0 0 0 2 0 133
FR 0 0 0 1 3 4 11 16 8 0 1 2 0 0 0 0 1 1 0 0 0 2 0 50
PT 1 0 0 0 0 2 3 5 2 0 1 1 0 1 0 0 0 0 0 0 0 0 0 16
ES1 1 1 0 1 9 6 16 21 8 1 5 8 0 0 0 1 1 0 0 0 0 2 0 81
ES2 1 1 0 0 4 3 8 6 6 0 3 3 0 0 9 2 0 0 1 0 0 0 0 47
IT1 1 2 0 1 6 3 19 28 15 2 10 5 0 0 2 5 0 2 2 0 0 1 2 106
IT2 2 0 0 0 0 1 3 9 1 0 0 0 0 0 0 0 33 0 0 0 0 0 0 49
YU 3 1 0 0 4 0 8 20 7 0 1 0 0 0 0 0 1 10 0 0 0 0 0 55
EL 2 2 0 0 2 1 7 17 8 3 1 0 0 0 0 1 0 0 7 0 0 0 0 51
HU 1 0 0 0 1 2 4 8 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 17
RO 0 0 0 0 1 2 1 2 2 0 2 1 0 0 0 1 0 0 0 0 0 0 0 12
PO 3 0 0 0 1 13 2 16 5 0 0 0 0 0 0 0 0 0 0 0 0 8 1 49
CZ 0 0 0 2 2 3 11 15 3 1 1 1 0 1 0 0 1 0 0 0 0 0 4 45
Total 68 13 39 28 154 288 426 841 295 12 53 31 0 2 11 10 88 14 11 0 0 64 9
Row, subpopulation of origin of reference individual; Column, subpopulation of origin of BOM of reference individual.
Underlined values are significantly higher than random expectation (P-valuer0.05), bold values are statistically significant after Bonferroni correction
(FWERr0.05).
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Supplementary Table 4). A graphical representation of the
BOM relationships between individuals is provided in a
directed graph illustrating the complexity of networks of
matches (Figure 3).
False positive rates
Although it is admittedly unlikely that a researcher would
actually carry out a population-based gene–disease associa-
tion study in which cases and controls were sampled from
different countries, without adjusting for population origin
in one way or another, measurement of the false positive
rates expected from such undertaking is of general interest
as a gauge of the magnitude of stratification pertaining in
the European population. Mock false positive rates for pairs
of subpopulations (Supplementary Table 3) ranged from
0.039 (CZ and PO) to 0.208 (DE1 and IT1), with a median of
0.070. Subpopulations sampled from the same political
country often had false positive rates indicative of little or
no population stratification, although this was not always
the case (DE1–DE2: 0.089). Many neighboring countries
also had false positive rates close to those expected under
the null hypothesis, indicating the absence of major
population differences as well (eg UK-IE: 0.042, NL-DK:
0.051, EL-YU: 0.047, CH-AT: 0.039, FR-DE2: 0.051).
Discussion
This is the first study to evaluate the genetic (ie, IBS-)
matched pair study design with genome-wide SNP data of a
large number of European individuals from across the
continent. The high number of best genetic-matching
partners found in different subpopulations corroborates
earlier reports of a considerable amount of genetic similarity
between the European subpopulations,4,10,14,25–27 parti-
cularly those in close geographic proximity. The surprising
inter-individual variability observed in terms of the number
of times a person was chosen as the best genetic-matching
partner of others does not necessarily imply that the
relationship between genetic and geographic distance in a
Figure 3 Directed graph illustrating the best overall matching (BOM) relationships between individuals. Circles represent individuals (2457 total)
and arrows point towards the respective BOM. The most frequently selected BOM (centre of the plot) was selected for 187 individuals.
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given sample hinges on a small number of people. Thus,
when the most frequently chosen matching partners were
barred in our analysis, the proportion of best matches found
outside the subpopulation of origin of the respective index
person remained virtually unchanged.
We observed that the best genetic-matching partner for a
genome-wide marker set such as the Affymetrix GeneChip
Human Mapping 500K Array cannot be predicted from a
small, specifically selected subset of markers alone, but that
the information required to make such predictions is
distributed evenly across all markers. This leads us to
conclude that, at least in Europe, the utility of the genetic-
matched pair study design depends critically on the
availability of comprehensive genotype information for
both cases and controls. In practise, this would mean that
shared controls should ideally be genotyped for all relevant
genome-wide marker sets, thereby allowing the chromo-
some-specific choice of best matching partners for given
case individuals on the basis of the remainder of the
genome.
A distinction must obviously be made between ASM,
collections of which have been described in recent
papers,14,25 – 28 and the BGM marker set that we attempted
to generate. As the genetic within-subpopulation variation
in Europe is much greater than the between-subpopulation
variation, it is not unlikely for any two individuals from
different subpopulations to be genetically more similar to
each other than any two individuals from the same
subpopulation. In this sense, an ASM marker set consists
of markers that differentiate subpopulations, whereas a
BGM marker set should contain variants that highlight
genetic similarity at the individual level. Although the two
concepts are complimentary, the marker sets fit to each
task need not be the same, and the existence of one set
does not necessitate the existence of the other. Obviously,
markers that arose on early branches of the corresponding,
region-specific coalescence tree of the extant Europeans
would provide good ASM, but they cannot at the same time
identify nearest neighbors at the tips of the tree. Such
identification requires a much higher resolution of the tree
topology, and therefore many more markers. Conse-
quently, no adequately sized BGM set could be constructed
in our study and the ASM set selected with established
methodology was no more capable of identifying the best
genetic-matching partner of an individual than a randomly
chosen marker set.
Recently, two independent applications of genetic
matching have been reported in the context of GWA
studies,4,29 both of which relied on information derived
from PCA of genotypes to match individuals. In the first
study, using US-American type 1 diabetes patients and
German controls, Luca et al4 carried out ‘full’ matching
wherein matches consist of clusters of individuals that
contain at least one case and one control. Matching was
based upon a distance measure with the top eigenvectors as
coordinates, weighted by the eigenvalues to exaggerate
differences in dimensions of greater importance. In the
second study, Heath et al29 undertook a PCA on a large pan-
European group of individuals and proposed a method to
predict the population affiliation of a sample of unknown
origin from the eigenvector matrix of its genotypes. As
both methods are likely to reduce spurious genetic
differences between cases and controls in disease associa-
tion studies, basing their matching criteria on eigenvectors
from PCA is strongly reminiscent of selecting ASM.
However, as we have shown above, matching with ASM is
less efficient than best overall genetic matching particu-
larly in Europe, where the within-subpopulation genetic
variation is known to be much greater than the between-
subpopulation variation. Indeed, the conclusion by Luca
et al4 that some individuals remain ‘unmatchable’ by their
approach is not surprising bearing in mind that ASM can
only capture a miniscule proportion of the actual inter-
individual genetic differences in a given population.
The false positive rates derived in our study from mock
genetic case-control experiments represent an upper limit
to the likely consequences of sharing samples in continent-
wide scientific collaborations. In this respect, the rate
estimates also rationalize collaborative genetic epidemio-
logical and pharmacogenetic research in Europe; from the
data we have compiled, it seems as if research projects
combining cases from neighboring subpopulations and
matching them against common control samples, such as
those provided by the WTCCC,3 GAIN1 and NGFN,9 may
indeed be valid.
In conclusion, we found that the pattern of pair-wise
genetic matching in the European population was more
complex than anticipated. Best genetic matches occurred
frequently across the continent in our study, and dispro-
portionately often involved a small group of individuals.
Ascertainment of a subset of markers that accurately
predicts best overall genetic matches turned out to be
infeasible.
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Additional Results
Some findings  produced  during  the  course  of  my  research  were  never 
published for various reasons. This may be because the results are not “earth 
shattering” enough, or because they did not fit well into the overall theme set forth 
in the articles, or perhaps the results were incomplete upon submission of the 
article,  or  they  constituted  negative  results  which  are  so  lamentably  under-
represented in the scientific literature. Here, I take the opportunity to present some 
interesting  results  produced  in  the  course  of  my  work  which  have  not  been 
previously published. The data set used in all  of the following analyses is that 
presented  in  Articles  One  and  Two  of  this  thesis.  The  hierarchical  clustering 
analysis and the multidimensional  scaling were performed as part  of  the initial 
exploratory  analysis  of  the  data  set.  The  sampling  strategy  experiments  were 
carried out with regard to observations which conflicted with previously published 
results. Selection experiments were conducted with the goal of discovering new 
genetic loci under selection. Observations about the distributions of the ancestry 
sensitive marker set (ASM) and the best genetic match (BGM) marker set were 
made to better understand why these ascertained marker sets proved to be less 
useful  than  anticipated.  All  data  analyses  was  performed  at  the  Institut  für 
Medizinische  Informatik  und  Statistik  on  the  Universitätsklinikum  Schleswig-
Holstein Campus, Kiel, Germany between 2007 and 2009.
Hierarchical Clustering of European Population Data
Various methods falling under the general heading of data clustering have 
been successfully performed on genetic data sets from large populations such as 
the one described in Articles Two and Three of this thesis. Hierarchical clustering 
has  been  used  to  effectively  differentiate  populations  on  a  global  or  intra-
continental scale64. Studies have found that as few as 50 randomly selected SNP 
markers  can  be  used  to  cluster  individuals  on  an  inter-continental  scale65,66. 
Model-based clustering methods including K-means clustering67 have been used 
to identify population structure at global68,69 as well as regional levels. Based on 
the success of  hierarchical  structuring reported in these and other studies,  we 
decided that this method should be applied to the genome-wide European data 
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set.
An  identity  by  state  matrix  containing  all  individual-individual  genetic 
distances was computed using all  quality controlled markers from the genome-
wide scan. Several different hierarchical clustering algorithms were applied to the 
matrix data using the hclust routine in the R statistical analysis software70. Of the 
algorithms  tested,  two  produced  reasonable  clusters:  the  average  linkage 
clustering algorithm (which minimizes the average distance of objects between 
clusters) and Ward's method (which minimizes the variance of objects within each 
cluster).  A cutoff  criterion  for  defining  cluster  groups  was  applied  to  clusters 
generated by each algorithm using the  cluster.stats routine  in  the R statistical 
analysis  software.  To  evaluate  the  robustness  of  the clusters,  a  bootstrapping 
method,  programed in R, was developed and the co-occurrence of  individuals 
within clusters was evaluated at each re-sampling. 
Unfortunately, the clusters generated in these experiments and tested by 
bootstrapping  were  unstable.  While  hierarchical  clustering  was  quite  powerful 
when applied to the large datasets in other studies, it was inadequate for resolving 
genetic structure in the comprehensive and diverse European data set used in this 
thesis  (Figure  2).  One  hypothesis  explaining  this  result  is  that  the  clustering 
methods applied are most effective under two conditions: 1) when the data being 
clustered  consists  of  multiple  relatively  distinct  groups,  as  is  the  case  with 
genotype data collected on a global scale from discrete populations, or 2) when 
the  structure  underlying  the clusters  consists  of  a  small  number  of  somewhat 
differentiated groups, as is the case in the more regional studies. The European 
population data used in this thesis consists of many subpopulations with highly 
overlapping  population  structure  and  the  clustering  methods  were  therefore 
unable  to  successfully  differentiate  the subpopulations  under  these conditions. 
Another hypothesis as to the failure of the clustering method is presented in the 
next section.
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Multidimensional Scaling of European Population Data
Multidimensional  Scaling (MDS) is  an ordination analysis  method which, 
like Principal Components Analysis, has also found widespread use in population 
genetic studies. MDS is typically employed in the analysis of population-based 
distance matrices (i.e. pairwise Fst or Φst) to quantify genetic structure. I have used 
MDS  in  published  studies  to  generate  multi-dimensional  plots  based  on  Y-
chromosome marker data depicting population differentiation in the German71 and 
Norwegian72 populations. Other studies have used distances between individuals 
rather  than  populations  for  MDS.  These  studies  use  identity-by-state  (IBS) 
matrices from autosomal  marker  genotypes to examine population structure in 
northern Europe73 and Japanese74 populations, and to test for population outliers 
in genome-wide association studies on a British75 population and a population of 
US Americans of European descent76. The application of this analytical method in 
the aforementioned studies inspired the decision to undertake MDS analysis on 
the IBS matrix computed for the European population featured in Articles Two and 
Three.  This  analysis  was  performed  using  the  MASS  package  from  the  R 
statistical  software  suite70.  Unfortunately,  MDS failed  to  achieve  a  satisfactory 
degree of separation of individuals from this data set (Figure 3). 
In light of the similar failing of the hierarchical clustering algorithms on the 
Figure 3. 
Multidimensional 
Scaling Analysis of the 
European population. A 
three dimensional plot.
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same IBS matrix, it may be hypothesized that the failure of both analysis methods 
is due to the loss of information occuring when an IBS matrix is generated from 
individual genotype data. Technically, MDS analysis is a special case of principal 
components  analysis77,  so  with  the  proper  data  transformation,  similar  results 
should be achievable with both methods. The success of the PCA analysis on the 
European data  set  was  attributable  in  large  part  a  method  published by  Nick 
Patterson  and  David  Reich20.  Their  method  did  not  involve  first  transforming 
individual genotypes into an IBS matrix. They instead applied MDS directly to the 
genotype matrix after the genotype values have been appropriately centered and 
normalized. The intuitive leap that led to this improved method was a deep insight 
on their part and has been subsequently adapted for use in MDS analysis78,79.
Effects of Sampling Strategy on Observed Genetic Structure
When Article Two was submitted for publication in May of 2008, it was one 
of many studies appearing around the time that analyzed a genome wide survey 
of genetic markers on samples of Europeans to determine population structure. 
Figure 4. Subsampling results on the human European population. A. 5 
samples from each population. B. Six northern vs. four southern 
populations.
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One of the precursors to these studies was published in 2006 by Michael F. Seldin 
et. al.21 Along with the typical genetic clines observed previously in other studies, 
they reported “evidence for major difference in population structure of northern 
and southern Europe”.  The study presented in Article Two notes a continuous 
gradient from south to north, with no apparent clustering. To try to resolve this 
contradiction,  a  sub-sampling  experiment  was  designed  and  executed  to 
determine  if  the  result  observed  by  the  Seldin  et.  al. could  be  an  artifact  of 
sampling bias.  Two causes for the observed clusters seemed likely 1) that the 
sample sizes were not large enough to give evidence of a smooth gradient or 2) 
that  the  population  sampling  distribution  did  not  cover  the  geographic  region 
densely enough. To determine if such sampling effects influenced the results, two 
types of subsamples were taken from our population. In the first experiment, a 
limited number of samples (n=5) from each population was taken. In the second, a 
selection, using the entire subpopulations, of southern (ES1, IT1, EL, RO) and 
northern  (UK,  NO,  SE,  DE1,  CZ,  AT)  subpopulations  was  made.  The  sample 
selection  criteria  were  designed  to  reflect  those  used  by  Seldin  et.  al. PCA 
analysis was done on both re-sampled data sets. PCA analysis was performed 
with  the  Eigensoft program  using  default  settings20 and  plotted  using  the  R 
statistical  analysis  software70 with  kernel  densities  drawn  by  the  adehabitat 
package80 with an 80% boundary. These experiments revealed a cluster pattern in 
both  circumstances  indicating  that  sample  size  (Figure  4.A.)  and  sampled 
population  distribution  (Figure  4.B.)  do  influence  the  observation  of  genetic 
structure. Ideally, the robustness of the limited sampling portion of the experiment 
would be tested by rigorous re-sampling. This was not done in a formal manner as 
it was decided not to pursue this line of argument against the Seldin et. al. paper 
in the published manuscript.
Evidence of Selection in OCA2/HERC2 and LCT/MCM6 Genes
Previous  studies  on  the  European  population  have  shown  evidence  of 
selection  at  two  distinct  genetic  loci:  one  locus  controlling  eye  color 
(OCA2/HERC2), and one controlling persistence of the lactase gene (LCT). Using 
the data set presented in Articles Two and Three, an exploratory analysis was 
undertaken to search for new, previously undiscovered genes under selection in 
the  European population.  Initially,  the  entire  European  sample  population  was 
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divided into two groups, representing northern and southern Europe. PLINK81 was 
used to perform association tests over the entire genome using one group as 
mock-cases and the other group as mock-controls. This procedure was repeated 
using  an  east-west  division  as  well  as  northeast-southwest  and  northwest-
southeast divisions. In the case of the north-south population division, exploratory 
analysis showed evidence of possible selection pressure in genetic regions on 
chromosomes 2 and 15 (Figure 5). These were verified to be the OCA2 (Figure 6) 
and LCT (Figure 7) loci which had already been well reported in the literature. All 
plots were generated using the UCSC Genome Browser web interface. The fact 
that validation of previously observed results is an under appreciated part of the 
scientific process, will not hinder those results from being reported here.
The locus on chromosome 15 (15q12-13) associated with the brown/blue 
eye  color  phenotype  was  first  described  in  the  Danish  population  in  199682. 
Subsequent association studies replicated this finding in Americans of European 
descent83,  Australians  of  European  descent84,85,  and  in  the  Dutch  population86. 
These studies were able to quantify the amount of variation attributed to this trait 
locus (QTL) to approximately 75%. The two genes of interest located in this region 
are oculocutaneous albinism II (OCA2) and hect domain & RLD 2 (HERC2). The 
function of  these two genes has not been precisely  elucidated.  They are both 
involved in processes related to melanine, one of the predominant pigments in 
determining  skin,  hair,  and  eye  color.  OCA2  is  though  to  be  involved  in  the 
trafficking  of  tyrosinase or  its  substrates87 which are important  in  melanosome 
maturation.  A mutation  in  HERC2,  which  is  located  just  upstream adjacent  to 
OCA2,  has  been  implicated  as  an  inhibitory  regulator  for  OCA287.  Strong 
association between eye color and the HERC2 locus has been demonstrated in 
the  Dutch  population88 and  in  Australians  of  European  descent89.  Selective 
advantages hypothesized for the OCA2 related mutations which lead not only to 
blue eye color, but to a paler skin phenotype are: 1) enhanced vitamin D synthesis 
in the lower sunlight conditions found at high latitudes, and 2) sexual selection, 
implying that prospective mates find this phenotype to be more attractive.
Genetic variation in the lactase gene, which is responsible for digestion of 
milk  sugar  (disaccharide  lactose,  or  simply  lactose),  has  been  much  more 
thoroughly  studied  than  the  OCA2/HERC2  genes  due  to  the  interest  of 
evolutionary biologists, anthropologists, and molecular geneticists,. Lactase is a 
membrane bound intestinal enzyme found in micovilli projecting into the lumen of 
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the small intestine. Lactase hydrolyzes lactose to monosaccharide galactose and 
glucose  which  are  then  absorbed.  The  first  scientific  evidence  that  levels  of 
lactase are highly variable in adult humans came in the 1960's despite the fact 
that individual differences in ability to digest milk have long been observed90. In 
most mammals, the ability to digest lactose subsides upon maturation, however 
some  humans  retain  this  ability  into  adulthood.  This  trait  displays  dominant 
autosomal  transmission91.  Early  studies  speculated  that  lactase  persistence  is 
common  only  in  certain  populations  with  long  traditions  of  pastoralism92.  The 
distribution of lactase persistence in Europe, Asia and Africa has since been well 
documented90 and manifests itself  as a gradient in Europe and India and as a 
patchy  distribution  throughout  Africa  and in  the  Middle  East.  The presence  of 
lactase persistence in  the European population has been shown to be almost 
completely correlated with a single haplotype which is most likely to have been the 
result  of  a  single  mutational  event.  An associated  locus,  MCM6,  contains  two 
regulatory regions for LCT. However, the African and Middle Eastern populations 
show  evidence  of  lactase  persistence  due  to  multiple  mutation  events.  The 
hypothesized selective advantage for the LCT mutant in northern Europe are 1) 
an additional nutritional advantage conferred by milk, and 2) the consumption of 
vitamin D counteracting an increased risk of developing rickets and osteomalacia 
which  can  occur  more  frequently  at  higher  latitudes  due  to  low  exposure  to 
sunlight. These selection hypothesis remain untested.
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Distribution  of  the  PCA-Correlation  Coefficient  in  an  Ancestry  Sensitive 
Marker Set
One of the as-yet unpublished results of the research on population genetic 
structure of the European population is the ascertainment of an Ancestry Sensitive 
Marker (ASM) set. An ASM set is defined as a subset of markers that captures 
much  of  the  genetic  structure  represented  in  the  complete  set  of  markers 
surveyed.  If  the  ASM  set  is  small  in  size  and  has  an  information  content 
comparable to that of the complete marker set,  it  can be utilized and result  in 
savings in genotyping expense. One of the methods used to ascertain an ASM set 
for the European population was adopted from the work of Paschou et. al.93 who 
described a procedure for  computing a PCA-correlation coefficient  (PCAcc) for 
each marker reflecting its correspondence to the top principal components of a 
PCA. By selecting an ASM set consisting of the markers with the highest PCAcc 
for  our  data  set,  it  was  hoped  that  a  useful  set  of  ASM  markers  could  be 
ascertained. This was done by sorting all the markers according to their PCAcc, 
larger coefficients indicating better correlation with the top principal components 
and by extension, higher information content for population differentiation. Though 
this  method  seemed  promising,  experiments  showed  that  marker  sets  small 
enough to be used as ASM sets could not represent the genetic structure of the 
complete marker set with sufficient resolution. Sometime after the publication of 
Article Two, an analysis was undertaken to estimate the individual contributions of 
each marker to the information contained of the PCA top principal components. It 
was obvious that the distribution of PCAcc was a long-tail distribution (Figure 8.A., 
see the Discussion and Conclusions Section for more about long-tail distributions) 
so visual  inspection  was done to determine whether  the distribution displayed 
power-law or log-normal properties. All plots were generated using the R statistical 
analysis software39 using the built-in plot, hist and dnorm functions. A data set with 
a power-law distribution can be recognized as having a linear appearance with a 
negative  slope  on  a  log-log  plot  (Figure  8.B.,  also  compare  with  Article  One, 
Figure  6).  To  visualize  the  distributions  correspondence  to  a  log-normal 
distribution, a histogram of the normalized absolute deviations (log(i) -μ)/σ was 
compared  to  the  standard  normal  curve  N(0,1) (Figure  8.C.,  also  compare  to 
Article One, Figure 6). A data set with a log-normal distribution has a histogram 
similar to the standard normal curve. 
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The most striking feature of the log-log plot (Figure 8.B.) is the rapid drop in 
magnitude of the PCAcc in the region of 150,000 markers (half of the data set). 
The distribution of markers before the bend shows an additional kink at marker 25. 
Although the section before the bend appears  to be linear  on the plot,  closer 
inspection reveals a curved distribution deviating from the regression line (data 
not shown). Inspection of the histogram of absolute deviations (Figure 8.C.) shows 
that the distribution has marked log-normal properties.
The observation that this distribution is a long-tail distribution can be used 
to  understand  why  the  ASM  marker  set  selection  was  unsuccessful.  The 
distribution suggests that as each marker is added to the ASM set, it contributes 
incrementally less additional information to the resolution of the genetic structure. 
If  a  small  number  of  markers  provides  insufficient  resolution,  then  very  large 
numbers of markers will  need to be added to make appreciable improvements. 
The  further  significance  of  this  power-law  distribution  is  presented  in  the 
Discussion and Conclusions.
Distribution of Information in the Best Genetic Match Marker Set
One of the primary results presented in Article Three (the examination of 
genetic similarity in the European population) is that no small set of markers can 
predict  the  best  genetic  match  with  the  degree  of  accuracy  approaching  the 
complete set of 300k markers. To come to this conclusion it was necessary to 
Figure 8. Plots depicting properties of the ASM marker sets PCA-
correlation coefficient distribution. A. Correlation vs. marker rank showing 
the long-tail B. Log(correlation) vs. log(marker rank) showing non-linearity, 
therefore poor correspondence to a power-law distribution C. Histogram of 
the normalized absolute deviations showing good correspondence with a 
log-normal distribution.
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incrementally  measure  the  predictive  accuracy  of  the  smaller  set  of  markers, 
referred to as the Best Genetic Match (BGM) set, as each marker was added. In 
Figure  1  of  Article  Three,  Δ represents  the  inverse  of  the  accuracy,  or  the 
inaccuracy of the BGM set in predicting the best genetic match. As more markers 
are added to the set, the inaccuracy (Δ) of the prediction of the set decreases. It is 
more convenient to think of the inverse of Δ as being a measure of the amount of 
information present in the BGM marker set. As more markers are added to the 
marker set, the information present in the marker set grows, as does its predictive 
accuracy. Sometime after the journal publication of Article Three, we completed an 
analysis of the distribution of the information contribution of each genetic marker 
in the BGM marker set. Because the forward analysis to generate BGM marker 
set was very computationally intensive, only 130 markers were ascertained for the 
set before the selection process was terminated. All  plots were generated using 
the  R  statistical  analysis  software39 using  the  built-in  plot,  hist and  dnorm 
functions.
An initial inspection of the distribution of information content shows that the 
curve is likely to be a long-tail curve (Figure 9.A.). Further analysis shows that the 
distribution  closely  resembles  a  power-law  distribution  (Figure  9.B.)  (power 
regression,  y  =  0.714  ·  x-1.054,  r2=0.9613052)  and  not  a  log-normal  distribution 
(Figure  9.C.).  The  first  four  markers  have  a  relatively  constant  information 
contribution, which would have allowed for the efficient selection of an accurately 
Figure  9. Plots  depicting  properties  of  the  BGM  marker  sets 
“Change in Delta” distribution.  A. Change in delta vs. marker rank 
showing the long-tail (extends to 300k markers).  B. Log(change in 
delta)  vs.  log(marker  rank)  showing  linearity,  therefore  good 
correspondence  to  a  power-law  distribution  C. Histogram  of  the 
normalized absolute deviations showing poor correspondence with a 
log-normal 
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predictive marker set  had it  continued through the rest of the distribution.  The 
observed  long-tail  properties  of  the  distribution  indicate  that  the  increase  in 
predictive performance of the BGM marker set gets smaller with each marker that 
is added to the set, in other words the rate of increase in accuracy of the marker 
set  decreases as it  gets larger,  and explains the failure in finding an accurate 
BGM marker set. The further significance of this distribution is presented in the 
Discussion and Conclusions section.
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Discussion and Conclusions
Long-tails, Microarrays, and Marker Sets
Gaining a better understanding of natural processes is the basic motivation 
behind all natural scientific work. It is often the case that scientific progress occurs 
in a haphazard manner with discoveries and advances made at an unpredictable 
pace and in unexpected directions. Due to the nature of this discovery processes, 
it is at times difficult to take notice of certain similarities inherent in the phenomena 
being observed. Sometimes, however, an underlying structure which highlights a 
common  feature  in  unrelated  processes  can  be  brought  forth  to  provide  an 
explanation for the observed phenomena. The properties of data set distributions 
are an example of an underlying structure which can emphasize such similarities.
The three articles presented in this thesis explore three different questions 
in  related  disciplines  of  biology:  functional  genomics,  population  genetics  and 
genetic epidemiology. Each of the three examines a different quantitative aspect 
of genetic information, one the level of expression of a gene, another the level of 
informativeness of a genetic marker in discriminating between individuals, and yet 
another the level in ability of a genetic marker to predict the best genetic match. 
As with all quantitative measures, each of these measurements, when taken in 
aggregate, creates a distribution. The distributions of quantitative measures often 
follow mathematically well- described models. Perhaps the best known of these is 
the  normal  or  Gaussian  distribution  which  describes  the  distribution  of  many 
natural phenomena. The distributions describing pattern of data we observed in all 
three  of  our  studies  are  from  a  class  called  long-tail,  fat-tail,  or  heavy-tail 
Figure 10. 
An example 
of a long-tail 
distribution, 
featuring 
the long tail 
(yellow) and 
a smaller 
number of 
large values 
(blue).
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distributions (Figure 10), examples of which include the power law and the log 
normal distributions. As was described in Article One, long-tail distributions feature 
an initial region with a small number of large values and a long tail with larger 
number of small values. Because the bulk of the data is in the tail, the tail exerts a 
large influence and is a characteristic feature of this type of distribution. Before 
further discussing the implications of long-tail distributions on the data presented 
here, it will be helpful to review the relevant results and relate them to the five 
fields of study introduced at the beginning of this thesis.
Microarray technology is a recurring theme in this thesis, a kind of thread 
that ties together all  of the research presented here.  This work began with an 
examination of a fundamental property of biological organisms, the distribution of 
gene expression levels as measured by expression screening microarrays. In all 
types of arrays examined, the distribution of expression levels was shown to be 
long-tail  distributions  exhibiting  varying  degrees  of  conformation  to  either  the 
power-law or log-normal distributions. Insights on the nature of these distributions 
were used to develop a normalization technique which conform to a version of the 
power-law distribution for discrete variables called Zipf's law, also known as the 
zeta distribution. The technique was compared to other normalization techniques 
in common use and was found to be especially appropriate for a specific type of 
microarray used in functional genomic studies called 'boutique' expression arrays 
which rely on standardized controls or housekeeping genes for normalization.
Making use of the same basic biotechnology, another common application 
of microarrays was examined, that of genotyping arrays. Here the focus switched 
to the field of population genetics by way of an extensive set of human genotype 
data made available through a large number of collaboration partners throughout 
Europe. The results of this study produced an impressive genetic to geographic 
correspondence with  PCA analysis  at  a  never  before  observed level  of  detail, 
further  clarifying  our  understanding  of  European  population  structure.  We 
generated  a  genetic  landscape  mirroring  the  geographic  landscape  of  the 
European  population  using  approximately  three  hundred  thousand  genetic 
markers.  One  contribution  of  the  study  was  an  improvement  to  genetic  map 
visualization techniques through the application of kernel densities to population 
plots. The search for an ancestry sensitive marker (ASM) set gave evidence that a 
small  set  of  markers  cannot  be  used  to  accurately  reconstruct  the  genetic 
structure  present  in  the  complete  data  set.  This  implies  that  the  genetic 
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information  that  reflects  population  differentiation  is  spread  across  the  entire 
genome and each marker makes only a small contribution to the overall structural 
information, exceptions being markers under selection (except for markers under 
selection such as OCA2 and HERC2).
Continuing  with  the  European genetic  data  set,  a  different  investigative 
thread was taken up which incorporated the field of genetic epidemiology. This 
time, instead of examining the markers informative for genetic differences, those 
associated  with  genetic  similarities  between  individuals  in  the  European 
population were investigated. This line of research resulted in several interesting 
discoveries about the genetic relationships between individuals on the continental 
level.  First,  considering  that  the  data  set  consisted  of  groups  of  individuals 
sampled from many populations throughout Europe, it might be naïvely assumed 
that individuals from the same population are most likely to be genetically similar 
to each other. However, it  was found that the most genetically similar matches 
were more likely (76%) to be made with an individual from outside the population. 
Another interesting observation about the distribution of the number of best overall 
genetic  matches  was  that  certain  rare  individuals  were  matched  to  many 
individuals.  These individuals  had an unusually  “average” genetic  makeup that 
allowed them to be selected as the best match for many others. A study design 
based on the idea of genetic matching was proposed in Article Three. The design 
has  superior  power  to  traditional  population-based  association  (case/control) 
studies because it reduces much of the stochastic “genetic noise” by pre-matching 
for similarity before tests for statistical association are performed. Having a small 
set of markers with which to predict the “Best Genetic Match” was deemed very 
useful  in  this  case.  The task of  searching for  such a set  was computationally 
intensive  and  utilized  a  massively  parallel  algorithm  developed  and  run  on  a 
computer cluster, however, the analysis was unable to find a small set of markers 
to  accurately  predict  BGM. This  led to  the conclusion that  genetic  information 
neccessary to identify the best genetic match is spread throughout the genome, 
with each marker making a small incremental contribution. This is similar to the 
situation observed with the ASM set of the population genetics study. 
Returning to the topic of data distributions,  expression microarrays were 
known to exhibit a long-tail distribution (Article One, Figure 6) before this series of 
studies  was  undertaken.  However,  the  observation  that  the  utility  of  genetic 
markers in differentiating European individuals (Additional Results, Figure 7) and 
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the predictive ability of markers in selecting the best genetic match (Additional 
Results, Figure 8) also follow long-tail distributions is a new finding. In fact, the 
scientific questions leading to the discovery of these distributions were, in both 
cases, premised on the hope that the distributions did not have long-tails. Both 
studies investigated a subset of markers containing the most informative portions 
of a larger set. However, upon acquisition of an appropriately-sized set of markers 
it was determined that the acquired set lacked the power to be useful for accurate 
prediction. At this point, a decision had to be made whether or not to continue 
expanding  the  marker  set  in  order  to  improve  predictive  accuracy.  An 
understanding  of  the  nature  of  long-tail  distributions  can  help  to  guide  this 
decision. Because it is known that the information necessary to make the marker 
set useful is in the long-tail, but including the long-tail makes the marker set too 
large to be practical, we can conclude that no marker set of appropriate size can 
be ascertained. The suggestion to use another method, stratagem, or algorithm to 
obtain an alternative marker set can be similarly countered. Therefore, in general, 
to adequately characterize genetic properties of relationships between individuals 
in the human population and gain a deeper understanding of genetic differences 
and similarities it is necessary to take into account the many small contributions of 
numerous genetic loci spread throughout the genome. It is noteworthy that this 
conclusion was reached investigating the underlying nature of the mathematical 
distribution of genetic information contained in these markers.
Outlook
In light of the attention focused on genome-wide genetic studies in the past 
few years and the contributions made by the research presented here to both 
population  genetics  and  genetic  epidemiology,  it  is  fruitful  here  to  explore 
opportunities for future research in these fields. 
In  the field  of  population genetics,  the four  major  forces affecting allele 
frequencies  are  mutation,  selection,  migration,  and genetic  drift.  An interesting 
application for the genome-wide data set used in this thesis would be to try to 
measure these parameters  in  the European population.  Somatic  mutation rate 
measurement is the most prohibitive of the four, as it involves long-term studies 
that repeatedly genotype participating individuals, which is not possible with the 
currently collected data. A cursory examination for effects of selection (Additional 
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Results) uncovered two loci  under selective pressure. Migration rates could be 
estimated by examining allele dispersion. This could be accomplished on a per 
marker basis by superimposing allele occurrence on the coordinates generated in 
the PCA analysis and producing genetic maps for each marker upon which spatial 
autocorrelation  analysis  could  be  performed.  These would  represent  a  sort  of 
genetic “snapshot” of the dynamic processes of allelic migration in time. Hundreds 
of  thousands of genetic  snapshots could then be conglomerated,  generating a 
map of genetic migration. The last parameter which could be examined is genetic 
drift,  which  is  influenced  by  the  estimated  effective  population  size.  Effective 
population size is a population genetic principle that is used to describe an ideal 
hypothetical population that responds to the effects of genetic drift  in the same 
way as the actual population, though the actual population may differ from the 
effective  population  in  many  respects.  In  human  populations,  two  important 
influences  on  the  effective  population  size  are  population  bottlenecks  and 
subsequent population expansions which are believed to have occurred several 
times in the past94. Other factors influencing effective population size on a less 
episodic, more temporally continuous scale are unequal contributions of gametes 
to  the  next  generation,  inbreeding,  and  overlapping  generations.  An  accurate 
estimation of effective population size would provide insights into the European 
population's history, as well as its spread and development. It would also allow 
predictions of the expected rate of allele frequency changes in the future. Because 
the accuracy of  estimated effective population size depends on the number of 
pairs of unlinked biallelic  markers used in the computation,  the unprecedented 
size of  the European genome-wide data set  (tens of millions of marker pairs), 
provides a unique opportunity to accurately estimate this parameter. Previously, 
studies have been performed using only the much smaller  HapMap sample of 
individuals (circa 60 individuals from Europe) on some 20 million marker pairs. 
The completion of  large scale sampling and genome-wide genotyping of  other 
populations would allow further estimates of population genetic parameters and 
provide additional interesting points of comparison.
All  studies  published to date on the European population have focused 
predominantly on the western half of the continent and less so on the eastern half. 
Thus, both sample size and the number of sites sampled have been biased in 
favor of the west. It would therefore be of interest to augment the research done 
thus far  with increased sampling from under-represented regions of  Europe to 
73
provide better estimations of population differentiation. Along similar lines, and if 
money  were  no  object,  genome-wide  genotyping  with  complete  population 
coverage  could  be  conducted  in  other  human  populations  and  used  for 
comparison to the European population. Comparing an area of similar geographic 
scale and population density to that of the European study would be desirable. 
Also, it would be prudent to choose an area with an indigenous population that 
has  not  experienced  massive  migrational  influx,  which  would  eliminate  the 
Americans and Australia from the prospective study locations. Good candidates 
might  be  a  region  of  sub-Saharan  Western  Africa  with  a  population  density 
comparable to that of Europe, or perhaps some subregion of Asia, perhaps in 
China. Additional studies in the two regions would shed light on the operation of 
many  population  genetic  mechanisms  because  these  those  regions  represent 
extremes when compared with the European population. The population histories 
of the two regions are very different, as African populations are more fragmented 
and China,  with its large and widespread distribution of Han Chinese (a single 
ethnic  group)  is  more  genetically  homogeneous.  One  might  expect  that  an 
extensive survey of autosomal markers would reveal a much more diverse and 
structured population in Africa and a less structured one in China when compared 
to  population  structures  determined  in  the  European  study. A comprehensive 
genetic study in the two regions would be far reaching in its ability to provide a 
better  understanding  of  the four  driving  factors  of  genetic  change:  migration, 
selection,  mutation,  and  genetic  drift.  Current  projects  focus  on  either 
microsatellites95 or  sex-linked96 markers  and  have  been  modest  in  both  the 
numbers of markers and the extent of sampling, making a large scale autosomal 
marker survey of African and Chinese populations a matter of scientific interest, 
even if not financially feasible.
In the field of genetic epidemiology, we proposed the genetic matched-pair 
study to provide more power in the analysis of population-based association data. 
After the publication of our proposed study design, Guan  et. al.97 published an 
application  and  evaluation  of  the  same study  design.  Their  simulation  studies 
showed that,  as predicted,  our study design does indeed reduce false-positive 
rates and retains high power to detect disease-associated markers as compared 
with traditional association study analysis methods. They also demonstrated that 
the  study  design  adequately  controls  for  population  stratification,  quote: 
“Effectively it treats every sample as a single population and compares it to the 
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most similar counterpart.” This property is especially useful in populations where 
admixture  is  an  important  consideration,  for  example  the  North  American 
population.  Based  on  these  results,  this  study  design  could  be  immediately 
adopted by the research community for use with existing data from genome-wide 
association studies that have appeared in the literature over the past few years. 
No new data would need to be collected, as the cases could be matched to the 
pools of existing controls for which all  the necessary genetic data has already 
been collected,  or  from existing pools  of  controls  maintained by the Welcome 
Trust38, NIH39, and PopGen40, among others. Given the inclination to high rates of 
false positives of the previously applied association study methods, there are two 
possible outcomes when comparing the already discovered association leads with 
those generated by the genetic  matching study design.  Either  the lead will  be 
verified giving weight to its status as an actual lead, or it will not be validated and 
should  probably  be  discarded  as  a  false  positive,  or  at  least  considered  with 
considerable prejudice. Also of interest would be the new leads generated under 
the genetic match study design which were not apparent in the original analysis, 
however these would still need to be verified before being considered as bona fide 
association leads.
In  summary,  exciting  advances  in  the  integrated  fields  of  genetic 
epidemiology,  population  genetics,  functional  genomics,  bioinformatics  and 
biotechnology are currently being made, breaking new ground and exploring new 
territory  with  discoveries  and technological  advancements to  bring us a better 
understanding of the processes underlying human genetic phenomena.
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